ORIGINAL RESEARCH original O OR ORI ORIG BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 1 1 0 0 1
Synthesis and synthesis S Sy Syn Synt BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 --- 3 10 1 0 0 0 1
(4-phenylpiperazin-1-yl)acetamide derivatives (4-phenylpiperazin-1-yl)acetamide ( (4 (4- (4-p BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 (---) 5 8 1 0 0 0 1
Krzysztof Kamin krzysztof K Kr Krz Krzy BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 •• 2 10 1 0 0 0 1
Received: 21 received: R Re Rec Rece BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 :/:/: 5 10 0 0 0 0 1
Ó The ó Ó Ó Ó Ó BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 0 ().. 4 10 0 0 0 0 1
Abstract Twenty-two abstract A Ab Abs Abst BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 ----(-- 7 7 0 0 0 0 1
azin-1-yl)acetamide derivatives azin-1-yl)acetamide a az azi azin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 1 --) 3 8 0 0 0 0 1
evaluated for evaluated e ev eva eval BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 9 0 0 0 0 1
of epilepsy. of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 9 0 0 0 0 1
of previously of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 - 1 8 0 0 0 0 1
2,5-diones in 2,5-diones 2 2, 2,5 2,5- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 1 ,-- 3 8 0 0 0 0 1
ged into ged g ge ged ged BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 . 1 8 0 0 0 0 1
synthesized in synthesized s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 9 0 0 0 0 1
amines with amines a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 no 0 8 0 0 0 0 1
2-chloro-1-(3-chlorophenyl)ethanone (1) 2-chloro-1-(3-chlorophenyl)ethanone 2 2- 2-c 2-ch BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 1 ---(-)()---[- 13 8 0 0 0 0 1
(trifluoromethyl)phenyl]ethanone (2). (trifluoromethyl)phenyl]ethanone ( (t (tr (tri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 ()](). 6 9 0 0 0 0 1
screening was screening s sc scr scre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 - 1 8 0 0 0 0 1
troshock (MES) troshock t tr tro tros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 () 2 7 0 0 0 0 1
screens in screens s sc scr scre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 /. 2 9 0 0 0 0 1
additionally in additionally a ad add addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 (-). 4 9 0 0 0 0 1
acute neurological acute a ac acu acut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 8 0 0 0 0 1
rotarod test. rotarod r ro rot rota BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 . 1 9 0 0 0 0 1
activity exclusively activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 8 0 0 0 0 1
3-(trifluoromethyl)anilide derivatives, 3-(trifluoromethyl)anilide 3 3- 3-( 3-(t BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 1 -(), 4 9 0 0 0 0 1
3-chloroanilide analogs 3-chloroanilide 3 3- 3-c 3-ch BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 1 -.- 3 8 0 0 0 0 1
size that size s si siz size BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 - 1 9 0 0 0 0 1
screen which screen s sc scr scre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 - 1 8 0 0 0 0 1
apy-resistant epilepsy. apy-resistant a ap apy apy- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 -., 3 10 0 0 0 0 1
derivative 20 derivative d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 - 1 8 0 0 0 0 1
ronal voltage-sensitive ronal r ro ron rona BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 -(). 4 8 0 0 0 0 1
studies for studies s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 9 0 0 0 0 1
of pyrrolidine-2,5-dione of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 -,- 3 8 0 0 0 0 1
activity. activity. activity. a ac act acti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 1 0 0 0 0 1
Keywords Phenylacetamides keywords K Ke Key Keyw BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 10 0 0 0 0 1
SAR studies sar S SA SAR SAR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 no 0 9 0 0 0 0 1
Epilepsy Epilepsy epilepsy E Ep Epi Epil BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 1 0 0 0 0 1
Introduction Introduction introduction I In Int Intr BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 no 0 10 0 0 0 0 1
Epilepsy is epilepsy E Ep Epi Epil BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 - 1 9 0 0 0 0 1
ders, affecting ders, d de der ders BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 ,.-. 4 9 0 0 0 0 1
It has it I It It It BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 , 1 9 0 0 0 0 1
recurring seizures recurring r re rec recu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 . 1 9 0 0 0 0 1
method of method m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 . 1 9 0 0 0 0 1
is a is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 no 0 8 0 0 0 0 1
reducing the reducing r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 ,, 2 9 0 0 0 0 1
inhibit the inhibit i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 no 0 9 0 0 0 0 1
and does and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 no 0 8 0 0 0 0 1
nervous system nervous n ne ner nerv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 (), 3 9 0 0 0 0 1
the disease. the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 ., 2 9 0 0 0 0 1
cannot be cannot c ca can cann BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 , 1 9 0 0 0 0 1
form of form f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 ,- 2 9 0 0 0 0 1
ment of ment m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 no 0 9 0 0 0 0 1
(WHO, 2010; (who, ( (W (WH (WHO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 6 (,;,;- 6 8 0 0 0 0 1
stein, 2003). stein, s st ste stei BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 ,)., 4 9 0 0 0 0 1
precisely definite, precisely p pr pre prec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 , 1 8 0 0 0 0 1
unequivocal mechanism unequivocal u un une uneq BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 - 1 9 0 0 0 0 1
(AEDs). This (aeds). ( (A (AE (AED BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 ().- 4 9 0 0 0 0 1
bilities of bilities b bi bil bili BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 no 0 9 0 0 0 0 1
of a of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 .,, 3 10 0 0 0 0 1
two different two t tw two two BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 : 1 9 0 0 0 0 1
modifications of modifications m mo mod modi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 no 0 9 0 0 0 0 1
entirely new entirely e en ent enti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 (.,). 5 9 0 0 0 0 1
consideration the consideration c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 ,- 2 8 0 0 0 0 1
ducted attempts ducted d du duc duct BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 no 0 9 0 0 0 0 1
for anticonvulsant for f fo for for BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 . 1 8 0 0 0 0 1
& Krzysztof & & & & & BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 10 no 0 10 0 1 0 0 1
k.kaminski@uj.edu.pl k.kaminski@uj.edu.pl k.kaminski@uj.edu.pl k k. k.k k.ka BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 1 0 0 10 .@.. 4 9 0 1 0 0 1
1 1 1 1 1 1 1 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 11 no 0 10 0 1 0 0 1
Department of department D De Dep Depa BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 ,, 2 9 0 1 0 0 1
Jagiellonian University jagiellonian J Ja Jag Jagi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 ,, 2 10 0 1 0 0 1
30-688 Krako 30-688 3 30 30- 30-6 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 11 -, 2 4 0 1 0 0 1
123 123 123 1 12 123 123 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 11 no 0 10 0 1 0 0 0
Med Chem med M Me Med Med BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 ():- 4 10 1 1 0 0 0
DOI 10.1007/s00044-015-1360-6 doi D DO DOI DOI BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 0 11 ./--- 5 9 1 1 0 0 0
MEDICINAL MEDICINAL medicinal M ME MED MEDI BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 no 0 10 1 1 0 0 0
CHEMISTRY CHEMISTRY chemistry C CH CHE CHEM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 no 0 10 1 1 0 0 0
RESEARCH RESEARCH research R RE RES RESE BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 0 11 no 0 9 1 1 0 0 0
researches, several researches, r re res rese BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,, 2 8 1 0 0 0 1
more rational more m mo mor more BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 9 1 0 0 0 1
described. Thus, described. d de des desc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ., 2 9 1 0 0 0 1
anticonvulsants is anticonvulsants a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 , 1 9 1 0 0 0 1
usually imide usually u us usu usua BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 8 1 0 0 0 1
tached to tached t ta tac tach BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (.,; 4 8 1 0 0 0 1
Bruno-Blanch et bruno-blanch B Br Bru Brun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 -.,;,). 7 9 1 0 0 0 1
template is template t te tem temp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,- 2 9 1 0 0 0 1
established AEDs, established e es est esta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 9 1 0 0 0 1
well as well w we wel well BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,..,,- 6 9 1 0 0 0 1
varacetam or varacetam v va var vara BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (,; 3 8 1 0 0 0 1
Bialer et bialer B Bi Bia Bial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 .,)(.). 7 5 1 0 0 0 1
Bearing in bearing B Be Bea Bear BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ,, 2 9 1 0 0 0 1
since many since s si sin sinc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 1 0 0 0 1
group of group g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -,-- 4 9 1 0 0 0 1
stituted at stituted s st sti stit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 -- 2 9 1 0 0 0 1
sition of sition s si sit siti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 . 1 9 1 0 0 0 1
Many of many M Ma Man Many BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 0 no 0 8 1 0 0 0 1
animal models animal a an ani anim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (.,,, 5 9 1 0 0 0 1
2011a, b; 2011a, 2 20 201 2011 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 0 0 ,;.,,; 6 8 1 0 0 0 1
Zago ´rska, zago Z Za Zag Zago BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,).- 4 9 1 0 0 0 1
tive doses tive t ti tiv tive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ()()- 5 9 1 0 0 0 1
zure test zure z zu zur zure BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 -,- 3 9 1 0 0 0 1
former research former f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (.,).. 6 9 1 0 0 0 1
Another important another A An Ano Anot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 8 1 0 0 0 1
convulsants as convulsants c co con conv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 8 1 0 0 0 1
clinical trials clinical c cl cli clin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 1 0 0 0 1
(Bruno-Blanch et (bruno-blanch ( (B (Br (Bru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (-.,;-,; 8 8 1 0 0 0 1
Luszczki, 2009; luszczki, L Lu Lus Lusz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,;.,;.,; 8 9 1 0 0 0 1
Ghidini et ghidini G Gh Ghi Ghid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 .,;.,;., 8 9 1 0 0 0 1
2002). It 2002). 2 20 200 2002 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 0 0 ). 2 9 1 0 0 0 1
possessed several possessed p po pos poss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 1 0 0 0 1
(chemically the (chemically ( (c (ch (che BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 () 2 9 1 0 0 0 1
and valnoctamide and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 1 0 0 0 1
of valproic of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (.). 4 4 1 0 0 0 1
Taking into taking T Ta Tak Taki BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 1 0 0 0 1
current studies, current c cu cur curr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 1 0 0 0 1
N-phenylacetamide derivatives n-phenylacetamide N N- N-p N-ph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 -. 2 9 1 0 0 0 1
These compounds these T Th The Thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 8 1 0 0 0 1
sponding pyrrolidine-2,5-dine sponding s sp spo spon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 -,-, 4 9 1 0 0 0 1
high anticonvulsant high h hi hig high BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 no 0 8 1 0 0 0 1
epilepsy (Obniska epilepsy e ep epi epil BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 (.,). 5 9 0 1 0 0 1
relied on relied r re rel reli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 no 0 9 0 1 0 0 1
(Fig. 4). (fig. ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 (.)., 5 10 0 1 0 0 1
elucidate how elucidate e el elu eluc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 / 1 8 0 1 0 0 1
affects anticonvulsant affects a af aff affe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 . 1 5 0 1 0 0 1
Results and results R Re Res Resu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 6 no 0 10 0 0 0 0 1
Chemistry Chemistry chemistry C Ch Che Chem BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 no 0 10 0 0 0 0 1
The synthesis the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 - 1 8 1 0 0 0 1
shown in shown s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 .---(- 6 9 1 0 0 0 1
chlorophenyl)ethanone chlorophenyl)ethanone chlorophenyl)ethanone c ch chl chlo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 ) 1 3 1 0 0 0 1
(1) (1) (1) ( (1 (1) (1) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 6 () 2 0 1 0 0 0 1
and and and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 no 0 0 1 0 0 0 1
2-chloro-1-[3-(tri- 2-chloro-1-[3-(tri- 2-chloro-1-[3-(tri- 2 2- 2-c 2-ch BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 6 ---[-(- 7 3 1 0 0 0 1
fluoromethyl)phenyl]ethanone (2) fluoromethyl)phenyl]ethanone f fl flu fluo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 )]()- 5 8 1 0 0 0 1
lation of lation l la lat lati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 -- 2 9 1 0 0 0 1
2-chloroacetyl chloride. 2-chloroacetyl 2 2- 2-c 2-ch BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 6 -. 2 9 1 0 0 0 1
0 °C 0 0 0 0 0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 6 no 0 9 1 0 0 0 1
(DCM) and (dcm) ( (D (DC (DCM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 6 (). 3 8 1 0 0 0 1
final compounds final f fi fin fina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 - 1 9 1 0 0 0 1
reaction of reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 no 0 9 1 0 0 0 1
obtained alkylating obtained o ob obt obta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 . 1 9 1 0 0 0 1
carried out carried c ca car carr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 - 1 9 1 0 0 0 1
solid system solid s so sol soli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 ,- 2 9 1 0 0 0 1
ate and ate a at ate ate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 . 1 9 1 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 - 1 8 1 0 0 0 1
phy. Compounds phy. p ph phy phy. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 .- 2 8 1 0 0 0 1
from 44 from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 . 1 8 1 0 0 0 1
chromatography (the chromatography c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 ( 1 8 1 0 0 0 1
in Fig. in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 6 .). 3 9 1 0 0 0 1
elemental analyses elemental e el ele elem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 (,,),, 6 9 1 0 0 0 1
NMR, LC/MS nmr, N NM NMR NMR, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 6 ,/. 3 8 1 0 0 0 1
analytical data analytical a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 . 1 9 1 0 0 0 1
The 1 the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 no 0 8 1 0 0 0 1
proton chemical proton p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 - 1 9 1 0 0 0 1
ture. The ture. t tu tur ture BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 . 1 9 1 0 0 0 1
as broad as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 (.-.). 6 8 1 0 0 0 1
linker at linker l li lin link BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 no 0 9 1 0 0 0 1
4.33 ppm. 4.33 4 4. 4.3 4.33 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 6 ..- 3 9 1 0 0 0 1
pected chemical pected p pe pec pect BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 no 0 10 1 0 0 0 1
d 6.81-7.86 d d d d d BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 0 6 .-..() 6 8 1 0 0 0 1
Fig. 1 fig. F Fi Fig Fig. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 . 1 10 1 1 0 0 1
3048 3048 3048 3 30 304 3048 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 11 no 0 1 0 1 0 0 0
Med Chem med M Me Med Med BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 11 ():- 4 10 0 1 0 0 0
123 123 123 1 12 123 123 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 11 no 0 10 1 1 0 0 0
broad singlet broad b br bro broa BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .. 2 9 1 1 0 0 1
piperazine fragment piperazine p pi pip pipe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (?) 3 9 1 1 0 0 1
at d at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .. 2 9 1 1 0 0 1
peaks at peaks p pe pea peak BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .,.,.. 6 9 1 1 0 0 1
to carbon to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 10 1 1 0 0 1
methylene linker methylene m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
peak at peak p pe pea peak BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 0 .. 2 8 1 1 0 0 1
aromatic rings aromatic a ar aro arom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
shifts within shifts s sh shi shif BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .-.. 4 9 1 1 0 0 1
172.1 ppm 172.1 1 17 172 172. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 .. 2 9 1 1 0 0 1
The 1 the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 1 1 0 0 1
within the within w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .-..-. 6 9 1 1 0 0 1
were ascribed were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 10 1 1 0 0 1
methylene linker methylene m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
singlet at singlet s si sin sing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .. 2 9 1 1 0 0 1
multiplets and multiplets m mu mul mult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 8 1 1 0 0 1
7.13-7.86 ppm. 7.13-7.86 7 7. 7.1 7.13 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 .-..() 6 9 1 1 0 0 1
singlet at singlet s si sin sing BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ..- 3 9 1 1 0 0 1
pholine fragment pholine p ph pho phol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 (?) 3 10 1 1 0 0 1
11.41 ppm. 11.41 1 11 11. 11.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 .. 2 8 1 1 0 0 1
peaks at peaks p pe pea peak BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .,.,.,.. 8 9 1 1 0 0 1
correspond to correspond c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 1 1 0 0 1
methylene linker methylene m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 . 1 9 1 1 0 0 1
carbons in carbons c ca car carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 1 1 0 0 1
within the within w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .-.. 4 8 1 1 0 0 1
171.5 ppm 171.5 1 17 171 171. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 .. 2 9 1 1 0 0 1
Anticonvulsant activity anticonvulsant A An Ant Anti BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
The preclinical the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 9 no 0 9 0 0 0 0 1
the treatment the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
animal seizure animal a an ani anim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 , 1 9 0 0 0 0 1
of human of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 . 1 9 0 0 0 0 1
Fig. 2 fig. F Fi Fig Fig. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 10 . 1 8 1 1 0 0 1
pyrrolidine-2,5-diones obtained pyrrolidine-2,5-diones p py pyr pyrr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 10 -,- 3 10 1 1 0 0 1
in the in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 10 no 0 7 1 1 0 0 1
Fig. 3 fig. F Fi Fig Fig. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 10 . 1 9 1 0 0 0 1
AEDs containing aeds A AE AED AEDs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 10 no 0 10 1 0 0 0 1
bound bound bound b bo bou boun BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 no 0 2 1 0 0 0 1
Fig. 4 fig. F Fi Fig Fig. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 . 1 8 1 0 0 0 1
pyrrolidine-2,5-dione core pyrrolidine-2,5-dione p py pyr pyrr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 11 -,- 3 8 1 0 0 0 1
fragment for fragment f fr fra frag BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 11 no 0 10 1 0 0 0 1
Med Chem med M Me Med Med BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 11 ():- 4 10 1 1 0 0 0
3049 3049 3049 3 30 304 3049 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 11 no 0 1 1 1 0 0 0
123 123 123 1 12 123 123 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 11 no 0 10 0 0 0 0 0
could potentially could c co cou coul BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 9 1 1 0 0 1
tivity, the tivity, t ti tiv tivi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,- 2 9 1 1 0 0 1
trazole (scPTZ) trazole t tr tra traz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ()'''' 6 10 1 1 0 0 1
early stages early e ea ear earl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 0 .- 2 9 1 1 0 0 1
independent animal independent i in ind inde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 9 1 1 0 0 1
cation of cation c ca cat cati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 . 1 9 1 1 0 0 1
uses an uses u us use uses BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 9 1 1 0 0 1
clonic seizures clonic c cl clo clon BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 1 1 0 0 1
model of model m mo mod mode BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 9 1 1 0 0 1
with or with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 9 1 1 0 0 1
scPTZ test scptz s sc scP scPT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 - 1 8 1 1 0 0 1
zures and zures z zu zur zure BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 no 0 9 1 1 0 0 1
seizure threshold. seizure s se sei seiz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 10 1 1 0 0 1
absence seizures absence a ab abs abse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (,). 4 5 1 1 0 0 1
Considering the considering C Co Con Cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 8 1 1 0 0 1
anticonvulsant activity anticonvulsant a an ant anti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 - 1 8 1 1 0 0 1
Scheme 1 scheme S Sc Sch Sche BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 10 ,- 2 10 1 0 0 0 1
3050 3050 3050 3 30 305 3050 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 11 no 0 1 1 1 0 0 0
Med Chem med M Me Med Med BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 11 ():- 4 10 1 1 0 0 0
123 123 123 1 12 123 123 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 11 no 0 10 0 1 0 0 0
established in established e es est esta BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,- 2 9 1 0 0 0 1
toneal (i.p.) toneal t to ton tone BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (..), 5 9 1 0 0 0 1
300 mg/kg. 300 3 30 300 300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 0 /. 2 9 1 0 0 0 1
time intervals-0.5 time t ti tim time BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -.., 4 9 1 0 0 0 1
primary anticonvulsant primary p pr pri prim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 9 1 0 0 0 1
toxicity (NT) toxicity t to tox toxi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (). 3 9 1 0 0 0 1
The results the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 1 0 0 0 1
summarized in summarized s su sum summ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 3 1 0 0 0 1
The compounds the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 1 0 0 0 1
the MES the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ., 2 9 1 0 0 0 1
anticonvulsant activity anticonvulsant a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 1 0 0 0 1
of substituent of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -.- 3 9 1 0 0 0 1
cept for cept c ce cep cept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 -(-)--(---)- 12 9 1 0 0 0 1
etamide (12)-effective etamide e et eta etam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ()-.( 5 9 1 0 0 0 1
100 mg/kg) 100 1 10 100 100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 0 /)-(-)---- 10 8 1 0 0 0 1
etamide (13) etamide e et eta etam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 () 2 9 1 0 0 0 1
(100 mg/kg (100 ( (1 (10 (100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 (/.,/), 7 8 1 0 0 0 1
3-chloroanilides (3-11) 3-chloroanilides 3 3- 3-c 3-ch BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 -(-)- 5 9 1 0 0 0 1
tivity. As tivity. t ti tiv tivi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ., 2 10 1 0 0 0 1
protection was protection p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -() 3 9 1 0 0 0 1
(14-24). Among (14-24). ( (1 (14 (14- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 (-).,, 6 9 1 0 0 0 1
for those for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -(-)(), 7 9 1 0 0 0 1
4-(2,3-dichlorophenyl)piperazine (17) 4-(2,3-dichlorophenyl)piperazine 4 4- 4-( 4-(2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 -(,-)()--- 10 9 1 0 0 0 1
yl-piperazine (21), yl-piperazine y yl yl- yl-p BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 -(), 4 9 1 0 0 0 1
dose of dose d do dos dose BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ///- 4 8 1 0 0 0 1
treatment times. treatment t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 9 1 0 0 0 1
observed for observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 9 1 0 0 0 1
tervals (300 tervals t te ter terv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (/.,/). 7 9 1 0 0 0 1
active compounds active a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 1 0 0 0 1
amine function amine a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (,,,) 5 9 1 0 0 0 1
MES seizures mes M ME MES MES BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 .. 2 9 1 0 0 0 1
delayed onset, delayed d de del dela BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,, 2 9 1 0 0 0 1
action. The action. a ac act acti BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 .-/ 3 8 1 0 0 0 1
showed also showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 (.).- 5 9 1 0 0 0 1
ences in ences e en enc ence BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 - 1 9 1 0 0 0 1
tion was tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 no 0 8 1 0 0 0 1
(24) or (24) ( (2 (24 (24) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 ()(,,,) 7 8 1 0 0 0 1
result from result r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 . 1 9 1 0 0 0 1
it is it i it it it BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 , 1 9 1 0 0 0 1
(higher clog (higher ( (h (hi (hig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 ()-,,, 6 8 1 0 0 0 1
mainly at mainly m ma mai main BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 , 1 8 1 0 0 0 1
effective only effective e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 .. 2 9 1 0 0 0 1
may be may m ma may may BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 1 0 0 1 6 no 0 9 1 0 0 0 1
compounds to compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 no 0 8 1 0 0 0 1
distribution to distribution d di dis dist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 . 1 9 1 0 0 0 1
that exchange that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 - 1 8 1 0 0 0 1
zylpiperazine (22) zylpiperazine z zy zyl zylp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 ()()- 5 8 1 0 0 0 1
creased anticonvulsant creased c cr cre crea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 . 1 8 1 0 0 0 1
revealed that revealed r re rev reve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 - 1 8 1 0 0 0 1
MES protection mes M ME MES MES BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 no 0 9 1 0 0 0 1
model AED model m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 .,- 3 8 1 0 0 0 1
convulsant protection convulsant c co con conv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 no 0 9 1 0 0 0 1
with respective with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 no 0 9 1 0 0 0 1
(Obniska et (obniska ( (O (Ob (Obn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 (.,). 5 9 1 0 0 0 1
of pyrrolidine-2,5-dione of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 -,- 3 9 1 0 0 0 1
for anticonvulsant for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 . 1 4 1 0 0 0 1
The pharmacological the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 6 no 0 8 1 0 0 0 1
studies proved studies s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 no 0 9 1 0 0 0 1
trifluoromethyl group trifluoromethyl t tr tri trif BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 - 1 9 1 0 0 0 1
tivity in tivity t ti tiv tivi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 ., 2 10 1 0 0 0 1
accepted that accepted a ac acc acce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 no 0 9 1 0 0 0 1
active molecules active a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 no 0 7 1 0 0 0 1
metabolic stability metabolic m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 - 1 9 1 0 0 0 1
reduction of reduction r re red redu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 . 1 8 1 0 0 0 1
Fig. 5 fig. F Fi Fig Fig. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 . 1 10 1 0 0 0 1
Med Chem med M Me Med Med BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 ():- 4 10 1 1 0 0 0
3051 3051 3051 3 30 305 3051 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 11 no 0 1 1 1 0 0 0
123 123 123 1 12 123 123 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 11 no 0 10 0 0 0 0 0
Moreover, the moreover, M Mo Mor More BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 ,, 2 8 0 1 0 0 1
relatively small relatively r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,- 2 8 0 1 0 0 1
tronegativity can tronegativity t tr tro tron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 8 0 1 0 0 1
electronic properties electronic e el ele elec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 1 0 0 1
significantly affect significantly s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 .,- 3 9 0 1 0 0 1
poration of poration p po por pora BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 9 0 1 0 0 1
increased lipophilicity increased i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (, 2 10 0 1 0 0 1
2006; Song 2006; 2 20 200 2006 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 2 0 ;.,;,;,). 9 9 0 1 0 0 1
should be should s sh sho shou BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 10 0 1 0 0 1
substitution on substitution s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 9 0 1 0 0 1
group of group g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 -[.]--[.]- 10 9 0 1 0 0 1
1,3-diones described 1,3-diones 1 1, 1,3 1,3- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 ,-(.,). 7 9 0 1 0 0 1
In the in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 1 (), 3 9 0 1 0 0 1
most of most m mo mos most BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ---() 5 9 0 1 0 0 1
electron-withdrawing substituents electron-withdrawing e el ele elec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 -(,,) 5 9 0 1 0 0 1
phenylpiperazine fragment phenylpiperazine p ph phe phen BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 no 0 9 0 1 0 0 1
Table 1 table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 ..(-) 5 10 0 1 0 0 1
No. No. no. N No No. No. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 . 1 0 0 1 0 0 1
R 1 r R R R R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 2 no 0 0 0 1 0 0 1
R 2 r R R R R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 2 no 0 0 0 1 0 0 1
X X x X X X X BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 2 no 0 0 0 1 0 0 1
R 3 r R R R R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 2 no 0 0 0 1 0 0 1
Intraperitoneal administration intraperitoneal I In Int Intr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 2 no 0 10 0 1 0 0 1
clog P clog c cl clo clog BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 2 0 1 0 0 1
MES b mes M ME MES MES BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 no 0 7 0 1 0 0 1
scPTZ c scptz s sc scP scPT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 no 0 10 0 1 0 0 1
NT d nt N NT NT NT BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 no 0 6 0 1 0 0 1
0.5 h 0.5 0 0. 0.5 0.5 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 . 1 10 0 1 0 0 1
4 h 4 4 4 4 4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 3 no 0 6 0 1 0 0 1
0.5 h 0.5 0 0. 0.5 0.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 . 1 10 0 1 0 0 1
4 h 4 4 4 4 4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 3 no 0 6 0 1 0 0 1
0.5 h 0.5 0 0. 0.5 0.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 . 1 10 0 1 0 0 1
4 h 4 4 4 4 4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 3 no 0 6 0 1 0 0 1
3 3 3 3 3 3 3 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 3 no 0 2 0 0 0 0 1
Cl Cl cl C Cl Cl Cl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 no 0 4 0 0 0 0 1
H H h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 no 0 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
3.15 3.15 3.15 3 3. 3.1 3.15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 . 1 7 0 0 0 0 1
4 4 4 4 4 4 4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 3 no 0 2 0 0 0 0 1
Cl Cl cl C Cl Cl Cl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 no 0 4 0 0 0 0 1
2-Cl 2-Cl 2-cl 2 2- 2-C 2-Cl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 - 1 7 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
3.71 3.71 3.71 3 3. 3.7 3.71 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 . 1 7 0 0 0 0 1
5 5 5 5 5 5 5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 3 no 0 2 0 0 0 0 1
Cl Cl cl C Cl Cl Cl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 no 0 4 0 0 0 0 1
4-Cl 4-Cl 4-cl 4 4- 4-C 4-Cl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 - 1 7 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
3.71 3.71 3.71 3 3. 3.7 3.71 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 . 1 7 0 0 0 0 1
6 6 6 6 6 6 6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 3 no 0 2 0 0 0 0 1
Cl Cl cl C Cl Cl Cl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 no 0 4 0 0 0 0 1
2,3-Cl 2,3-Cl 2,3-cl 2 2, 2,3 2,3- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 ,- 2 10 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
4.26 4.26 4.26 4 4. 4.2 4.26 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 . 1 7 0 0 0 0 1
7 7 7 7 7 7 7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 3 no 0 2 0 0 0 0 1
Cl Cl cl C Cl Cl Cl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 no 0 4 0 0 0 0 1
2-F 2-F 2-f 2 2- 2-F 2-F BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 - 1 5 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
3.31 3.31 3.31 3 3. 3.3 3.31 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 . 1 7 0 0 0 0 1
8 8 8 8 8 8 8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 3 no 0 2 0 0 0 0 1
Cl Cl cl C Cl Cl Cl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 no 0 4 0 0 0 0 1
4-F 4-F 4-f 4 4- 4-F 4-F BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 - 1 5 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
3.31 3.31 3.31 3 3. 3.3 3.31 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 . 1 7 0 0 0 0 1
9 9 9 9 9 9 9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 3 no 0 2 0 0 0 0 1
Cl Cl cl C Cl Cl Cl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 no 0 4 0 0 0 0 1
3-CF 3 3-cf 3 3- 3-C 3-CF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 - 1 10 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
4.07 4.07 4.07 4 4. 4.0 4.07 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 . 1 7 0 0 0 0 1
10 10 10 1 10 10 10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 3 no 0 4 0 0 0 0 1
Cl Cl cl C Cl Cl Cl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 no 0 4 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 - 1 1 0 0 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 no 0 2 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 no 0 10 0 0 0 0 1
- - - - - - - BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 2 0 0 0 0 1
1.72 1.72 1.72 1 1. 1.7 1.72 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 . 1 10 0 0 0 0 1
11 11 11 1 11 11 11 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 6 0 0 0 0 1
Cl Cl cl C Cl Cl Cl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 no 0 6 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 2 0 0 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 no 0 4 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 2 0 0 0 0 1
300 300 300 3 30 300 300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 8 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 2 0 0 0 0 1
2.80 2.80 2.80 2 2. 2.8 2.80 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 . 1 10 0 0 0 0 1
12 12 12 1 12 12 12 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 4 0 0 0 0 1
Cl Cl cl C Cl Cl Cl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 no 0 4 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 no 0 2 0 0 0 0 1
-CH 3 -ch - -C -CH -CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 - 1 8 0 0 0 0 1
100 100 100 1 10 100 100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 5 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
1.07 1.07 1.07 1 1. 1.0 1.07 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 . 1 7 0 0 0 0 1
13 13 13 1 13 13 13 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 4 0 0 0 0 1
Cl Cl cl C Cl Cl Cl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 no 0 4 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
O O o O O O O BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 no 0 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
100 100 100 1 10 100 100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 5 0 0 0 0 1
300 300 300 3 30 300 300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 5 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
300 300 300 3 30 300 300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 5 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
0.92 0.92 0.92 0 0. 0.9 0.92 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 . 1 7 0 0 0 0 1
14 14 14 1 14 14 14 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 4 0 0 0 0 1
CF 3 cf C CF CF CF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 no 0 7 0 0 0 0 1
H H h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 no 0 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
100 100 100 1 10 100 100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 5 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
300 Z 300 3 30 300 300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 8 0 0 0 0 1
300 300 300 3 30 300 300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 5 0 0 0 0 1
3.51 3.51 3.51 3 3. 3.5 3.51 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 . 1 7 0 0 0 0 1
15 15 15 1 15 15 15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 4 0 0 0 0 1
CF 3 cf C CF CF CF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 no 0 7 0 0 0 0 1
2-Cl 2-Cl 2-cl 2 2- 2-C 2-Cl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 - 1 7 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
4.07 4.07 4.07 4 4. 4.0 4.07 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 . 1 7 0 0 0 0 1
16 16 16 1 16 16 16 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 4 0 0 0 0 1
CF 3 cf C CF CF CF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 no 0 7 0 0 0 0 1
4-Cl 4-Cl 4-cl 4 4- 4-C 4-Cl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 - 1 7 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
100 100 100 1 10 100 100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 5 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
4.07 4.07 4.07 4 4. 4.0 4.07 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 . 1 7 0 0 0 0 1
17 17 17 1 17 17 17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 4 0 0 0 0 1
CF 3 cf C CF CF CF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 no 0 7 0 0 0 0 1
2,3-Cl 2,3-Cl 2,3-cl 2 2, 2,3 2,3- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 ,- 2 10 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
4.63 4.63 4.63 4 4. 4.6 4.63 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 . 1 7 0 0 0 0 1
18 18 18 1 18 18 18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 4 0 0 0 0 1
CF 3 cf C CF CF CF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 no 0 7 0 0 0 0 1
2-F 2-F 2-f 2 2- 2-F 2-F BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 - 1 5 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
100 100 100 1 10 100 100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 5 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
3.67 3.67 3.67 3 3. 3.6 3.67 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 . 1 7 0 0 0 0 1
19 19 19 1 19 19 19 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 4 0 0 0 0 1
CF 3 cf C CF CF CF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 no 0 7 0 0 0 0 1
4-F 4-F 4-f 4 4- 4-F 4-F BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 - 1 5 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
300 300 300 3 30 300 300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 5 0 0 0 0 1
100 100 100 1 10 100 100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 5 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
300 300 300 3 30 300 300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 5 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
3.67 3.67 3.67 3 3. 3.6 3.67 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 . 1 7 0 0 0 0 1
20 20 20 2 20 20 20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 4 0 0 0 0 1
CF 3 cf C CF CF CF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 no 0 7 0 0 0 0 1
3-CF 3 3-cf 3 3- 3-C 3-CF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 - 1 10 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
100 100 100 1 10 100 100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 5 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
4.43 4.43 4.43 4 4. 4.4 4.43 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 . 1 7 0 0 0 0 1
21 21 21 2 21 21 21 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 5 no 0 4 0 0 0 0 1
CF 3 cf C CF CF CF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 no 0 7 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 - 1 1 0 0 0 0 1
N N n N N N N BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 no 0 2 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
N N n N N N N BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
- - - - - - - BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 - 1 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 - 1 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 - 1 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 - 1 2 0 0 0 0 1
300 300 300 3 30 300 300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 8 no 0 8 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 - 1 2 0 0 0 0 1
2.09 2.09 2.09 2 2. 2.0 2.09 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 . 1 10 0 0 0 0 1
22 22 22 2 22 22 22 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 8 no 0 4 0 0 0 0 1
CF 3 cf C CF CF CF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 7 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 - 1 1 0 0 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 2 0 0 0 0 1
300 300 300 3 30 300 300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 8 no 0 5 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 - 1 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 - 1 1 0 0 0 0 1
300 33 300 3 30 300 300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 - 1 1 0 0 0 0 1
3.17 3.17 3.17 3 3. 3.1 3.17 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 . 1 7 0 0 0 0 1
23 23 23 2 23 23 23 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 9 no 0 2 0 0 0 0 1
CF 3 cf C CF CF CF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 3 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 - 1 0 0 0 0 0 1
N N n N N N N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 1 0 0 0 0 1
-(CH 2 -(ch - -( -(C -(CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 -()- 4 10 0 0 0 0 1
300 300 300 3 30 300 300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 9 no 0 2 0 0 0 0 1
300 300 300 3 30 300 300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 9 no 0 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 - 1 0 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 - 1 0 0 0 0 0 1
300 300 300 3 30 300 300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 9 no 0 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 - 1 0 0 0 0 0 1
0.92 0.92 0.92 0 0. 0.9 0.92 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 9 . 1 3 0 0 0 0 1
24 24 24 2 24 24 24 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 9 no 0 2 0 0 0 0 1
CF 3 cf C CF CF CF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 3 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 - 1 0 0 0 0 0 1
O O o O O O O BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 1 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 - 1 0 0 0 0 0 1
100 100 100 1 10 100 100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 9 no 0 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 - 1 0 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 - 1 0 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 - 1 0 0 0 0 0 1
100 100 100 1 10 100 100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 9 no 0 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 - 1 0 0 0 0 0 1
1.28 1.28 1.28 1 1. 1.2 1.28 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 9 . 1 3 0 0 0 0 1
Phenytoin f phenytoin P Ph Phe Phen BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 10 0 0 0 0 1
30 30 30 3 30 30 30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 9 no 0 2 0 0 0 0 1
30 30 30 3 30 30 30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 9 no 0 2 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 - 1 0 0 0 0 0 1
- - - - - - - BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 9 - 1 0 0 0 0 0 1
100 100 100 1 10 100 100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 9 no 0 3 0 0 0 0 1
100 100 100 1 10 100 100 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 9 no 0 3 0 0 0 0 1
Response comments: response R Re Res Resp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 9 :, 2 4 0 0 0 0 1
a Doses a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 2 9 ,/. 3 10 0 0 0 0 1
more animals more m mo mor more BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 . 1 9 0 0 0 0 1
b Maximal b b b b b BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 2 9 no 0 2 0 0 0 0 1
c Subcutaneous c c c c c BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 2 10 no 0 10 0 0 0 0 1
d Neurotoxicity d d d d d BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 2 10 no 0 10 0 0 0 0 1
e clog e e e e e BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 2 11 ,..(,,, 7 10 0 0 0 0 1
USA) USA) usa) U US USA USA) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 ) 1 0 0 0 0 0 1
f Phenytoin, f f f f f BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 2 11 ,,/ 3 7 0 0 0 0 1
3052 3052 3052 3 30 305 3052 BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 11 no 0 1 0 1 0 0 0
Med Chem med M Me Med Med BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 ():- 4 10 0 1 0 0 0
123 123 123 1 12 123 123 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 11 no 0 10 0 1 0 0 0
maximum dose maximum m ma max maxi BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (/). 4 7 0 0 0 0 1
derivatives, namely derivatives, d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,,,,,-- 7 8 0 0 0 0 1
toxicity at toxicity t to tox toxi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 /., 3 9 0 0 0 0 1
showed respiratory showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
revealed tremors revealed r re rev reve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 8 0 0 0 0 1
compound 24 compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 /. 2 9 0 0 0 0 1
According to according A Ac Acc Acco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 8 0 0 0 0 1
positions, three positions, p po pos posi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,, 2 8 0 0 0 0 1
protection in protection p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
anticonvulsant activity anticonvulsant a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 () 2 8 0 0 0 0 1
after oral after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (..)/ 5 10 0 0 0 0 1
kg. This kg. k kg kg. kg. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ., 2 9 0 0 0 0 1
time of time t ti tim time BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ()- 3 9 0 0 0 0 1
sant activity sant s sa san sant BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 . 1 9 0 0 0 0 1
Table 2. table T Ta Tab Tabl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 1 0 0 0 0 1
Among derivatives among A Am Amo Amon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 9 0 0 0 0 1
animals at animals a an ani anim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 9 0 0 0 0 1
in 25 in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 0 .. 2 9 0 0 0 0 1
25 % 25 2 25 25 25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 0 .() 3 9 0 0 0 0 1
(25). All (25). ( (2 (25 (25) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 (). 3 8 0 0 0 0 1
impairment in impairment i im imp impa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ( 1 9 0 0 0 0 1
Table 2). table T Ta Tab Tabl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 ). 2 8 0 0 0 0 1
than phenytoin than t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
in different in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 0 . 1 4 0 0 0 0 1
On the on O On On On BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 8 0 0 0 0 1
20 was 20 2 20 20 20 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
parameters (ED parameters p pa par para BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 ()... 5 9 0 0 0 0 1
quantitative evaluation quantitative q qu qua quan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 no 0 9 0 0 0 0 1
(ED 50 (ed ( (E (ED (ED BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 ()() 4 9 0 0 0 0 1
estimated TPE-2 estimated e es est esti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 -. 2 9 0 0 0 0 1
along with along a al alo alon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 -, 2 8 0 0 0 0 1
ethosuximide and ethosuximide e et eth etho BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 -. 2 8 0 0 0 0 1
The quantitative the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 no 0 8 0 0 0 0 1
than phenytoin than t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 (),, 4 9 0 0 0 0 1
potent than potent p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 . 1 10 0 0 0 0 1
emphasized that emphasized e em emp emph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 no 0 9 0 0 0 0 1
protective indexes protective p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 no 0 8 0 0 0 0 1
AEDs. Furthermore, aeds. A AE AED AEDs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 ., 2 9 0 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 3 no 0 8 0 0 0 0 1
Fig. 2. fig. F Fi Fig Fig. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 ..- 3 9 0 0 0 0 1
cinimide ring cinimide c ci cin cini BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 . 1 6 0 0 0 0 1
In the in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 3 , 1 9 0 0 0 0 1
compounds 12, compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 ,, 2 7 0 0 0 0 1
evaluation of evaluation e ev eva eval BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 no 0 9 0 0 0 0 1
6-Hz test 6-hz 6 6- 6-H 6-Hz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 -(). 4 9 0 0 0 0 1
part of part p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 --- 3 9 0 0 0 0 1
tection among tection t te tec tect BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 no 0 8 0 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 3 /.- 3 9 0 0 0 0 1
has been has h ha has has BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 - 1 9 0 0 0 0 1
(Barton et (barton ( (B (Ba (Bar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 (.,).,- 7 9 0 0 0 0 1
suggested to suggested s su sug sugg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 - 1 9 0 0 0 0 1
with a with w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 no 0 9 0 0 0 0 1
Table 2 table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 () 2 10 0 0 0 0 1
No. No. no. N No No. No. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 . 1 1 0 0 0 0 1
Oral administration oral O Or Ora Oral BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 7 no 0 10 0 0 0 0 1
0.25 h 0.25 0 0. 0.2 0.25 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 . 1 10 0 0 0 0 1
0.5 h 0.5 0 0. 0.5 0.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 . 1 8 0 0 0 0 1
1 h 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 7 no 0 5 0 0 0 0 1
2 h 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 7 no 0 5 0 0 0 0 1
4 h 4 4 4 4 4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 7 no 0 5 0 0 0 0 1
13 13 13 1 13 13 13 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 8 no 0 7 0 0 0 0 1
0/4 0/4 0/4 0 0/ 0/4 0/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 10 0 0 0 0 1
1/4 1/4 1/4 1 1/ 1/4 1/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 10 0 0 0 0 1
0/4 0/4 0/4 0 0/ 0/4 0/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 10 0 0 0 0 1
0/4 0/4 0/4 0 0/ 0/4 0/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 10 0 0 0 0 1
0/4 0/4 0/4 0 0/ 0/4 0/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 10 0 0 0 0 1
20 20 20 2 20 20 20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 8 no 0 7 0 0 0 0 1
0/4 0/4 0/4 0 0/ 0/4 0/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 10 0 0 0 0 1
1/4 1/4 1/4 1 1/ 1/4 1/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 10 0 0 0 0 1
0/4 0/4 0/4 0 0/ 0/4 0/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 10 0 0 0 0 1
2/4 2/4 2/4 2 2/ 2/4 2/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 10 0 0 0 0 1
0/4 0/4 0/4 0 0/ 0/4 0/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 10 0 0 0 0 1
22 22 22 2 22 22 22 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 8 no 0 7 0 0 0 0 1
1/4 1/4 1/4 1 1/ 1/4 1/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 10 0 0 0 0 1
1/4 1/4 1/4 1 1/ 1/4 1/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 10 0 0 0 0 1
1/4 1/4 1/4 1 1/ 1/4 1/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 10 0 0 0 0 1
1/4 1/4 1/4 1 1/ 1/4 1/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 10 0 0 0 0 1
1/4 1/4 1/4 1 1/ 1/4 1/4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 10 0 0 0 0 1
Phenytoin b phenytoin P Ph Phe Phen BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
1/4 1/4 1/4 1 1/ 1/4 1/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 3 0 0 0 0 1
4/4 4/4 4/4 4 4/ 4/4 4/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 3 0 0 0 0 1
3/4 3/4 3/4 3 3/ 3/4 3/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 3 0 0 0 0 1
3/4 3/4 3/4 3 3/ 3/4 3/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 3 0 0 0 0 1
3/4 3/4 3/4 3 3/ 3/4 3/4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 / 1 3 0 0 0 0 1
a Dose a a a a a BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 3 8 /.:/ 4 10 0 0 0 0 1
b Phenytoin, b b b b b BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 3 9 ,,/ 3 10 0 0 0 0 1
Table 3 table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 .. 2 10 0 1 0 0 1
No. No. no. N No No. No. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 . 1 1 0 1 0 0 1
TPE (h) tpe T TP TPE TPE BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 () 2 4 0 1 0 0 1
ED 50 ed E ED ED ED BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 3 9 (/) 3 9 0 1 0 0 1
ED 50 ed E ED ED ED BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 3 9 (/) 3 10 0 1 0 0 1
TD 50 td T TD TD TD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 3 9 (/) 3 8 0 1 0 0 1
PI (TD pi P PI PI PI BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 (/) 3 9 0 1 0 0 1
20 20 20 2 20 20 20 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 10 no 0 1 0 1 0 0 1
2 2 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 10 no 0 1 0 1 0 0 1
52.30 (46.38-60.22) 52.30 5 52 52. 52.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 .(.-.) 6 10 0 1 0 0 1
ND ND nd N ND ND ND BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 1 0 1 0 0 1
[500 [500 [500 [ [5 [50 [500 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 [ 1 2 0 1 0 0 1
[9.56 (MES) [9.56 [ [9 [9. [9.5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 [.() 4 6 0 1 0 0 1
Valproic acid valproic V Va Val Valp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 7 0 1 0 0 1
1 1 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 10 no 0 0 0 1 0 0 1
485 (324-677) 485 4 48 485 485 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 10 (-) 3 6 0 1 0 0 1
646 (466-869) 646 6 64 646 646 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 10 (-) 3 6 0 1 0 0 1
784 (503-1176) 784 7 78 784 784 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 10 (-) 3 6 0 1 0 0 1
1.6 (MES) 1.6 1 1. 1.6 1.6 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 .().() 6 10 0 1 0 0 1
Phenytoin d phenytoin P Ph Phe Phen BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 6 0 1 0 0 1
1 1 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 10 no 0 1 0 1 0 0 1
28.10 (20.7-35.2) 28.10 2 28 28. 28.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 .(.-.) 6 10 0 1 0 0 1
[500 [500 [500 [ [5 [50 [500 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 [ 1 2 0 1 0 0 1
[100 [100 [100 [ [1 [10 [100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 [ 1 2 0 1 0 0 1
[3.6 (MES) [3.6 [ [3 [3. [3.6 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 [.() 4 6 0 1 0 0 1
ND not nd N ND ND ND BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 8 0 1 0 0 1
a Time a a a a a BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
b Results b b b b b BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 3 11 (,, 3 10 0 1 0 0 1
NT neurotoxicity, nt N NT NT NT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 ,) 2 2 0 1 0 0 1
c Protective c c c c c BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 3 11 (/) 3 2 0 1 0 0 1
d Reference d d d d d BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 3 11 / 1 10 0 1 0 0 1
Med Chem med M Me Med Med BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 ():- 4 10 0 1 0 0 0
3053 3053 3053 3 30 305 3053 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 11 no 0 1 0 1 0 0 0
123 123 123 1 12 123 123 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 11 no 0 10 0 0 0 0 0
of anticonvulsant of o of of of BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 0 0 0 0 1
hypothesis is hypothesis h hy hyp hypo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 8 0 0 0 0 1
demonstrated efficacy demonstrated d de dem demo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 9 0 0 0 0 1
sies. It sies. s si sie sies BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 . 1 10 0 0 0 0 1
PTZ seizures ptz P PT PTZ PTZ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 , 1 8 0 0 0 0 1
effectiveness in effectiveness e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 9 0 0 0 0 1
partial epilepsy partial p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (,)., 5 9 0 0 0 0 1
that the that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -- 2 9 0 0 0 0 1
seizure agents seizure s se sei seiz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 9 0 0 0 0 1
known mechanism known k kn kno know BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 7 0 0 0 0 1
The results the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
morpholine derivative morpholine m mo mor morp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
at 0.25 at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ., 2 9 0 0 0 0 1
0.5 h 0.5 0 0. 0.5 0.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 ./(..). 7 9 0 0 0 0 1
protected 75 protected p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ... 3 9 0 0 0 0 1
compounds 19 compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
of animals of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ().,(). 7 9 0 0 0 0 1
None of none N No Non None BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
mentioned studies. mentioned m me men ment BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 3 0 0 0 0 1
In vitro in I In In In BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 2 no 0 10 0 0 0 0 1
Intensive studies intensive I In Int Inte BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 9 0 0 0 0 1
events taking events e ev eve even BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 2 no 0 9 0 0 0 0 1
insight into insight i in ins insi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 8 0 0 0 0 1
might be might m mi mig migh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 . 1 9 0 0 0 0 1
and regulating and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 8 0 0 0 0 1
suppression of suppression s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 - 1 9 0 0 0 0 1
channels (VGSCs) channels c ch cha chan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ()(,)., 7 8 0 0 0 0 1
the brain the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 9 0 0 0 0 1
numerous chemically numerous n nu num nume BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 8 0 0 0 0 1
and carbamazepine and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ( 1 9 0 0 0 0 1
and Lo and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 ,;.,;.,). 9 10 0 0 0 0 1
Using radioligand using U Us Usi Usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 ,- 2 9 0 0 0 0 1
ciates have ciates c ci cia ciat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 no 0 9 0 0 0 0 1
drugs and drugs d dr dru drug BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 () 2 9 0 0 0 0 1
channels from channels c ch cha chan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 (,;- 4 9 0 0 0 0 1
terall et terall t te ter tera BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 .,). 4 9 0 0 0 0 1
influx of influx i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 9 0 0 0 0 1
BTX, which btx, B BT BTX BTX, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 2 ,(., 4 8 0 0 0 0 1
1984). Electrophysiological 1984). 1 19 198 1984 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 3 2 ). 2 9 0 0 0 0 1
demonstrate a demonstrate d de dem demo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 -- 2 9 0 0 0 0 1
of sodium of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 (- 2 9 0 0 0 0 1
low et low l lo low low BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 5 .,;.,). 7 9 0 0 0 0 1
suggest that suggest s su sug sugg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 9 0 0 0 0 1
agents underlies agents a ag age agen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 9 0 0 0 0 1
stressed here stressed s st str stre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 10 0 0 0 0 1
compounds active compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 9 0 0 0 0 1
to activity to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 9 0 0 0 0 1
for the for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 8 0 0 0 0 1
for Na? for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ?()[] 5 9 0 0 0 0 1
batrachotoxin as batrachotoxin b ba bat batr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 (,). 4 8 0 0 0 0 1
binding was binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 8 0 0 0 0 1
binding of binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 9 0 0 0 0 1
values for values v va val valu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ,,, 3 9 0 0 0 0 1
100, and 100, 1 10 100 100, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 ,.- 3 8 0 0 0 0 1
plicate. The plicate. p pl pli plic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 .. 2 7 0 0 0 0 1
As it as A As As As BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 8 0 0 0 0 1
moderate binder moderate m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 - 1 9 0 0 0 0 1
channel at channel c ch cha chan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 -. 2 9 0 0 0 0 1
may suggest may m ma may may BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 1 0 0 3 5 no 0 9 0 0 0 0 1
than only than t th tha than BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 4 0 0 0 0 1
Experimental Experimental experimental E Ex Exp Expe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
Chemistry Chemistry chemistry C Ch Che Chem BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
All the all A Al All All BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 - 1 8 0 0 0 0 1
ma-Aldrich (St. ma-aldrich m ma ma- ma-A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 -(.,) 5 9 0 0 0 0 1
purification. Melting purification. p pu pur puri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 .(.) 4 9 0 0 0 0 1
capillaries on capillaries c ca cap capi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 ( 1 10 0 0 0 0 1
Labortechnik, Flawil, labortechnik, L La Lab Labo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 ,,). 4 9 0 0 0 0 1
HPLC analyses hplc H HP HPL HPLC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 no 0 7 0 0 0 0 1
Separation Module separation S Se Sep Sepa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 - 1 8 0 0 0 0 1
tector (Waters tector t te tec tect BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 ().- 4 8 0 0 0 0 1
column (4.6 column c co col colu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 (.). 4 8 0 0 0 0 1
as follows: as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 :(/.),(- 8 8 0 0 0 0 1
tonitrile/0.1 % tonitrile/0.1 t to ton toni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 /.),/, 6 8 0 0 0 0 1
0-100 % 0-100 0 0- 0-1 0-10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 -, 2 8 0 0 0 0 1
was 10 was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 .(/) 4 9 0 0 0 0 1
were prepared were w we wer were BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 no 0 9 0 0 0 0 1
Table 4 table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 -..(-) 6 10 0 1 0 0 1
No. No. no. N No No. No. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 . 1 1 0 1 0 0 1
Intraperitoneal injection intraperitoneal I In Int Intr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
0.25 h 0.25 0 0. 0.2 0.25 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 10 0 1 0 0 1
0.5 h 0.5 0 0. 0.5 0.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 8 0 1 0 0 1
1 h 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 10 no 0 5 0 1 0 0 1
2 h 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 10 no 0 5 0 1 0 0 1
4 h 4 4 4 4 4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 10 no 0 5 0 1 0 0 1
12 12 12 1 12 12 12 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 10 no 0 7 0 0 0 0 1
3/4 3/4 3/4 3 3/ 3/4 3/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
3/4 3/4 3/4 3 3/ 3/4 3/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
0/4 0/4 0/4 0 0/ 0/4 0/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
0/4 0/4 0/4 0 0/ 0/4 0/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
0/4 0/4 0/4 0 0/ 0/4 0/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
19 19 19 1 19 19 19 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 10 no 0 7 0 0 0 0 1
0/4 0/4 0/4 0 0/ 0/4 0/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
0/4 0/4 0/4 0 0/ 0/4 0/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
0/4 0/4 0/4 0 0/ 0/4 0/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
0/4 0/4 0/4 0 0/ 0/4 0/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
1/4 1/4 1/4 1 1/ 1/4 1/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
20 20 20 2 20 20 20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 10 no 0 7 0 0 0 0 1
1/4 1/4 1/4 1 1/ 1/4 1/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
0/4 0/4 0/4 0 0/ 0/4 0/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
0/4 0/4 0/4 0 0/ 0/4 0/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
1/4 1/4 1/4 1 1/ 1/4 1/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
1/4 1/4 1/4 1 1/ 1/4 1/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
24 24 24 2 24 24 24 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 10 no 0 7 0 0 0 0 1
4/4 4/4 4/4 4 4/ 4/4 4/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
2/4 2/4 2/4 2 2/ 2/4 2/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
3/4 3/4 3/4 3 3/ 3/4 3/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
0/4 0/4 0/4 0 0/ 0/4 0/4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
0/4 0/4 0/4 0 0/ 0/4 0/4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 / 1 10 0 0 0 0 1
Current 32 current C Cu Cur Curr BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 11 no 0 1 0 0 0 0 1
a Dose a a a a a BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 4 11 /.:/ 4 10 0 0 0 0 1
3054 3054 3054 3 30 305 3054 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 11 no 0 1 0 1 0 0 0
Med Chem med M Me Med Med BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 ():- 4 10 0 1 0 0 0
123 123 123 1 12 123 123 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 11 no 0 10 0 1 0 0 0
at wavelengths at a at at at BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 .() 3 9 0 0 0 0 1
given in given g gi giv give BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 .,, 3 9 0 0 0 0 1
carried out carried c ca car carr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
III Elemental iii I II III III BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 (,). 4 9 0 0 0 0 1
elemental analyses elemental e el ele elem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 9 0 0 0 0 1
values. 1 values. v va val valu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ., 2 8 0 0 0 0 1
obtained in obtained o ob obt obta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (., 3 9 0 0 0 0 1
Palo Alto, palo P Pa Pal Palo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 ,,),( 5 9 0 0 0 0 1
NMR), 75 nmr), N NM NMR NMR) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 ),()(). 7 8 0 0 0 0 1
Chemical shifts chemical C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 () 2 9 0 0 0 0 1
TMS d tms T TM TMS TMS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 (),. 4 9 0 0 0 0 1
expressed in expressed e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ().- 4 9 0 0 0 0 1
sented by sented s se sen sent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 :(), 4 9 0 0 0 0 1
(broad singlet), (broad ( (b (br (bro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (),(),(), 9 10 0 0 0 0 1
(triplet) and (triplet) ( (t (tr (tri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ()(). 5 9 0 0 0 0 1
on Waters on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
(Waters, Milford, (waters, ( (W (Wa (Wat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (,,)., 6 8 0 0 0 0 1
1.7 lm, 1.7 1 1. 1.7 1.7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .,.(,, 6 8 0 0 0 0 1
USA). USA). usa). U US USA USA) BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 ). 2 0 0 0 0 0 1
General procedure general G Ge Gen Gene BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 2 no 0 10 0 0 0 0 1
and 2 and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 no 0 1 0 0 0 0 1
A total a A A A A BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 4 2 .--- 4 8 0 0 0 0 1
fluoromethylaniline was fluoromethylaniline f fl flu fluo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 2 no 0 9 0 0 0 0 1
mixed with mixed m mi mix mixe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 - 1 8 0 0 0 0 1
droxide. Then, droxide. d dr dro drox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 2 .,.-- 5 9 0 0 0 0 1
solved in solved s so sol solv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 (). 3 9 0 0 0 0 1
During that during D Du Dur Duri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 2 ,. 2 10 0 0 0 0 1
After the after A Af Aft Afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 2 , 1 10 0 0 0 0 1
for 2 for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 ., 2 9 0 0 0 0 1
with saturated with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 , 1 9 0 0 0 0 1
brine. The brine. b br bri brin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 . 1 9 0 0 0 0 1
sodium sulfate sodium s so sod sodi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 no 0 9 0 0 0 0 1
obtain white obtain o ob obt obta BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 . 1 5 0 0 0 0 1
2-Chloro-N-(3-chlorophenyl)acetamide (1) 2-chloro-n-(3-chlorophenyl)acetamide 2 2- 2-C 2-Ch BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 ---(-)()- 9 8 0 1 0 0 1
dery crystals; dery d de der dery BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 4 3 ;-;:.; 6 8 0 1 0 0 1
NMR (CDCl nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 ():.(,,--),.-.(,, 17 9 0 1 0 0 1
ArH), 7.58-7.78 arh), A Ar ArH ArH) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 ),.-.(,,,.),.(,, 16 8 0 1 0 0 1
ArH), 8.31 arh), A Ar ArH ArH) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 ),.(,,);(,): 12 8 0 1 0 0 1
43.3 (-CH 43.3 4 43 43. 43.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 .(--),.,.,.,.,.,. 17 9 0 1 0 0 1
(6C aromatic (6c ( (6 (6C (6C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 (),.(--).-:.( 13 9 0 1 0 0 1
[M?H] ? [m?h] [ [M [M? [M?H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 [?]?)..(.):,.; 14 10 0 1 0 0 1
H, 3.46; h, H H, H, H, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 ,.;,..:,.;,.,,.. 16 8 0 1 0 0 1
2-Chloro-N-[3-(trifluoromethyl)phenyl]acetamide (2) 2-chloro-n-[3-(trifluoromethyl)phenyl]acetamide 2 2- 2-C 2-Ch BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 ---[-()]() 10 9 0 1 0 0 1
powdery crystals; powdery p po pow powd BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ;-;:.; 6 8 0 1 0 0 1
1 H 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 4 5 (,):.(,,--), 12 8 0 1 0 0 1
7.42-7.52 (m, 7.42-7.52 7 7. 7.4 7.42 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 .-.(,,),.-.(,,, 15 7 0 1 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 5 .),.(,,),.(,,); 15 9 0 1 0 0 1
NMR (75 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 (,):.(--),.(-), 15 8 0 1 0 0 1
117.1, 118.6, 117.1, 1 11 117 117. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 .,.,.,.,.,.,.(), 16 10 0 1 0 0 1
168.8 (-CO-). 168.8 1 16 168 168. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 .(--).-:.([?]?). 16 9 0 1 0 0 1
Anal. Calcd anal. A An Ana Anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 .(.):,.;,.; 11 9 0 1 0 0 1
N, 5.89. n, N N, N, N, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 ,..:,.;,.,,.. 13 6 0 1 0 0 1
General procedure general G Ge Gen Gene BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 6 no 0 10 0 0 0 0 1
3-24 3-24 3-24 3 3- 3-2 3-24 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 - 1 0 0 0 0 0 1
A total a A A A A BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 4 6 . 1 9 0 0 0 0 1
amount of amount a am amo amou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 no 0 9 0 0 0 0 1
in 10 in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 6 ..- 3 9 0 0 0 0 1
bonate and bonate b bo bon bona BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 no 0 8 0 0 0 0 1
added, and added, a ad add adde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 , 1 10 0 0 0 0 1
at a at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 ()., 4 10 0 0 0 0 1
inorganic ingredients inorganic i in ino inor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 no 0 9 0 0 0 0 1
distilled off distilled d di dis dist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 . 1 9 0 0 0 0 1
were obtained were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 .- 2 8 0 0 0 0 1
were purified were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 no 0 9 0 0 0 0 1
(Merck, Darmstadt, (merck, ( (M (Me (Mer BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 (,,)- 5 8 0 0 0 0 1
methanol (9: methanol m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 (:./). 6 9 0 0 0 0 1
oily form, oily o oi oil oily BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 ,-,,-, 6 8 0 0 0 0 1
converted into converted c co con conv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 no 0 9 0 0 0 0 1
saturated with saturated s sa sat satu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 .- 2 9 0 0 0 0 1
hydrous ethanol. hydrous h hy hyd hydr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 . 1 2 0 0 0 0 1
N-(3-chlorophenyl)-2-(4-phenylpiperazin-1-yl)acetamide N-(3-chlorophenyl)-2-(4-phenylpiperazin-1-yl)acetamide n-(3-chlorophenyl)-2-(4-phenylpiperazin-1-yl)acetamide N N- N-( N-(3 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 -(-)--(---) 11 8 0 0 0 0 1
monohydrochloride (3) monohydrochloride m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 ();. 4 8 0 0 0 0 1
199-201 °C; 199-201 1 19 199 199- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 -;:.;(, 7 8 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 -):.-.(,,),.(,, 15 9 0 0 0 0 1
-CH 2 -ch - -C -CH -CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 --),.-.(,,),.-.(,,), 20 9 0 0 0 0 1
7.12-7.29 (m, 7.12-7.29 7 7. 7.1 7.12 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 .-.(,,),.-.(,,), 16 7 0 0 0 0 1
7.53-7.60 (m, 7.53-7.60 7 7. 7.5 7.53 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 .-.(,,),.-.(,,),. 17 8 0 0 0 0 1
(brs, 1H, (brs, ( (b (br (brs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 (,,),.(,,?);(, 14 8 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 -):.(--),.(--),.(--), 21 10 0 0 0 0 1
53.3 (-CH 53.3 5 53 53. 53.3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 .(--),.(--),.,.,.,., 20 9 0 0 0 0 1
130.2, 130.9, 130.2, 1 13 130 130. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 .,.,.,.,.(),. 13 9 0 0 0 0 1
(-CO-). ESI-MS: (-co-). ( (- (-C (-CO BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 (--).-:.([?]?). 15 8 0 0 0 0 1
Table 5 table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 10 ?() 3 10 0 1 0 0 1
No. No. no. N No No. No. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 10 . 1 1 0 1 0 0 1
Concentration (lM) concentration C Co Con Conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 10 () 2 6 0 1 0 0 1
% Inhibition % % % % % BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 10 no 0 4 0 1 0 0 1
of control of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 no 0 10 0 1 0 0 1
20 20 20 2 20 20 20 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 10 no 0 7 0 1 0 0 1
1 1 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 4 10 no 0 5 0 1 0 0 1
4.2 4.2 4.2 4 4. 4.2 4.2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 10 . 1 10 0 1 0 0 1
10 10 10 1 10 10 10 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 10 no 0 7 0 1 0 0 1
7.5 7.5 7.5 7 7. 7.5 7.5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 10 . 1 10 0 1 0 0 1
100 100 100 1 10 100 100 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 10 no 0 8 0 1 0 0 1
10.8 10.8 10.8 1 10 10. 10.8 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 10 . 1 10 0 1 0 0 1
500 500 500 5 50 500 500 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 10 no 0 8 0 1 0 0 1
46.7 46.7 46.7 4 46 46. 46.7 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 10 . 1 10 0 1 0 0 1
a Compounds a a a a a BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 4 11 - 1 8 0 1 0 0 1
tions from tions t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 11 no 0 10 0 1 0 0 1
[ 3 [ [ [ [ [ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 11 []-. 4 9 0 1 0 0 1
inhibition higher inhibition i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 11 no 0 9 0 1 0 0 1
effects of effects e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 11 ; 1 9 0 1 0 0 1
25 and 25 2 25 25 25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 11 ; 1 8 0 1 0 0 1
showing an showing s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 11 no 0 9 0 1 0 0 1
and mostly and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 11 no 0 10 0 1 0 0 1
level level level l le lev leve BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 11 no 0 0 0 1 0 0 1
Med Chem med M Me Med Med BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 ():- 4 10 0 1 0 0 0
3055 3055 3055 3 30 305 3055 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 11 no 0 1 0 1 0 0 0
123 123 123 1 12 123 123 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 11 no 0 10 0 0 0 0 0
Anal. Calcd anal. A An Ana Anal BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 .(.):,.;,.; 11 10 0 1 0 0 1
N, 11.47. n, N N, N, N, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ,..:,.;,.,,.. 13 6 0 1 0 0 1
N-(3-chlorophenyl)-2-[4-(2-chlorophenyl)piperazin-1-yl] N-(3-chlorophenyl)-2-[4-(2-chlorophenyl)piperazin-1-yl] n-(3-chlorophenyl)-2-[4-(2-chlorophenyl)piperazin-1-yl] N N- N-( N-(3 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 -(-)--[-(-)--] 14 8 0 1 0 0 1
acetamide monohydrochloride acetamide a ac ace acet BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 () 2 7 0 1 0 0 1
crystals; mp. crystals; c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ;.-;:.; 7 8 0 1 0 0 1
NMR (300 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 (,-):.-.(,,- 12 8 0 1 0 0 1
azine), 4.33 azine), a az azi azin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 ),.(,,--),.-.(,,), 18 8 0 1 0 0 1
7.29-7.45 (m, 7.29-7.45 7 7. 7.2 7.29 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .-.(,,),.(,,,., 15 8 0 1 0 0 1
1.92, 0.91 1.92, 1 1. 1.9 1.92 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,.),.-.(,,),.(,,), 19 9 0 1 0 0 1
11.43 (brs, 11.43 1 11 11. 11.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .(,,?);(,-): 12 8 0 1 0 0 1
51.8 (-CH 51.8 5 51 51. 51.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .(--),.(--),.(--),.(--), 24 10 0 1 0 0 1
54.9 (-CH 54.9 5 54 54. 54.9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .(--),.,.,.,.,.,., 18 9 0 1 0 0 1
126.5, 130.3, 126.5, 1 12 126 126. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,.,.,.,.,.(),. 15 10 0 1 0 0 1
(-CO-). ESI-MS: (-co-). ( (- (-C (-CO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 (--).-:.([?]?).. 16 9 0 1 0 0 1
Calcd for calcd C Ca Cal Calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 (.):,.;,.;, 11 9 0 1 0 0 1
10.49. Found: 10.49. 1 10 10. 10.4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ..:,.;,.;,.. 12 6 0 1 0 0 1
N-(3-chlorophenyl)-2-[4-(4-chlorophenyl)piperazin-1-yl] N-(3-chlorophenyl)-2-[4-(4-chlorophenyl)piperazin-1-yl] n-(3-chlorophenyl)-2-[4-(4-chlorophenyl)piperazin-1-yl] N N- N-( N-(3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 -(-)--[-(-)--] 14 8 0 0 0 0 1
acetamide monohydrochloride acetamide a ac ace acet BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 1 () 2 6 0 0 0 0 1
crystals; mp. crystals; c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 ;.-;:.; 7 7 0 0 0 0 1
NMR (300 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 1 (,-):.-.(,,- 12 7 0 0 0 0 1
azine), 4.30 azine), a az azi azin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 1 ),.(,,--),.-.(,,), 18 7 0 0 0 0 1
7.15-7.20 (m, 7.15-7.20 7 7. 7.1 7.15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 .-.(,,),.-.(,,),.(, 19 8 0 0 0 0 1
1H, ArH, 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 ,,.),.(,,,.), 13 7 0 0 0 0 1
7.83-7.84 (m, 7.83-7.84 7 7. 7.8 7.83 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 .-.(,,),.(,,),.(,, 18 8 0 0 0 0 1
?NH); 13 ?nh); ? ?N ?NH ?NH) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 1 ?);(,-):.(--), 14 7 0 0 0 0 1
52.8 (-CH 52.8 5 52 52. 52.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 .(--),.(--),.(--),.(--), 24 9 0 0 0 0 1
112.6, 114.5, 112.6, 1 11 112 112. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 .,.,.,.,.,.,.,., 16 8 0 0 0 0 1
141.5, 146.4 141.5, 1 14 141 141. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 .,.(),.(--).-:. 15 8 0 0 0 0 1
(C 18 (c ( (C (C (C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 1 ([?]?).. 8 10 0 0 0 0 1
(400.73): C, (400.73): ( (4 (40 (400 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 (.):,.;,.;,..:,.;, 18 8 0 0 0 0 1
5.09; N, 5.09; 5 5. 5.0 5.09 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 .;,.. 5 2 0 0 0 0 1
N-(3-chlorophenyl)-2-[4-(2,3-dichlorophenyl)piperazin-1-yl] N-(3-chlorophenyl)-2-[4-(2,3-dichlorophenyl)piperazin-1-yl] n-(3-chlorophenyl)-2-[4-(2,3-dichlorophenyl)piperazin-1-yl] N N- N-( N-(3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 -(-)--[-(,-)--] 15 8 0 0 0 0 1
acetamide monohydrochloride acetamide a ac ace acet BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 ()- 3 7 0 0 0 0 1
tals; mp. tals; t ta tal tals BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 ;.-;:.; 7 7 0 0 0 0 1
(300 MHz, (300 ( (3 (30 (300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 (,-):.-.(,,), 13 7 0 0 0 0 1
4.31 (s, 4.31 4 4. 4.3 4.31 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 .(,,--),.-.(,,),.-. 19 8 0 0 0 0 1
(m, 3H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 (,,),.-.(,,),.-.(,, 19 8 0 0 0 0 1
ArH), 10.79 arh), A Ar ArH ArH) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 3 ),.(,,),.(,,?); 15 7 0 0 0 0 1
NMR (75 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 3 (,-):.(--),.(-- 15 8 0 0 0 0 1
), 53.9 ), ) ), ), ), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 3 ),.(--),.(--),.(--),.,., 24 9 0 0 0 0 1
117.5, 118.7, 117.5, 1 11 117 117. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 .,.,.,.,.,.,.,., 16 8 0 0 0 0 1
140.8, 147.1 140.8, 1 14 140 140. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 .,.(),.(--).-:. 15 8 0 0 0 0 1
(C 18 (c ( (C (C (C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 3 ([?]?).. 8 10 0 0 0 0 1
(435.17): C, (435.17): ( (4 (43 (435 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 (.):,.;,.;,..:,.;, 18 8 0 0 0 0 1
4.48; N, 4.48; 4 4. 4.4 4.48 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 .;,.. 5 2 0 0 0 0 1
N-(3-chlorophenyl)-2-[4-(2-fluorophenyl)piperazin-1-yl] N-(3-chlorophenyl)-2-[4-(2-fluorophenyl)piperazin-1-yl] n-(3-chlorophenyl)-2-[4-(2-fluorophenyl)piperazin-1-yl] N N- N-( N-(3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 -(-)--[-(-)--] 14 10 0 0 0 0 1
acetamide monohydrochloride acetamide a ac ace acet BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 () 2 8 0 0 0 0 1
crystals; mp. crystals; c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ;.-;:.; 7 9 0 0 0 0 1
NMR (300 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 (,-):.-.(,,- 12 9 0 0 0 0 1
azine), 4.32 azine), a az azi azin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 ),.(,,--),.-.(,,), 18 9 0 0 0 0 1
7.33-7.42 (m, 7.33-7.42 7 7. 7.3 7.33 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 .-.(,,),.(,,,., 15 9 0 0 0 0 1
2.03, 1.03 2.03, 2 2. 2.0 2.03 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 .,.),.(,,,.),.(, 16 9 0 1 0 0 1
1H, NH), 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 ,),.(,,?);(, 12 7 0 1 0 0 1
CDCl 3 cdcl C CD CDC CDCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 ):.(--),.(--),.(--),. 21 10 0 1 0 0 1
(-CH 2 (-ch ( (- (-C (-CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 (--),.(--),.,.,.,.,., 21 9 0 1 0 0 1
122.9, 125.4, 122.9, 1 12 122 122. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 .,.,.,.,.,.,.(), 16 10 0 1 0 0 1
171.9 (-CO-); 171.9 1 17 171 171. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 .(--);(,-):-.- 14 8 0 1 0 0 1
(-122.83) (m, (-122.83) ( (- (-1 (-12 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 (-.)(,).-:.( 12 8 0 1 0 0 1
[M?H] ? [m?h] [ [M [M? [M?H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 [?]?)..(.):, 12 9 0 1 0 0 1
56.26; H, 56.26; 5 56 56. 56.2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 .;,.;,..:,.;,.;,.. 18 9 0 1 0 0 1
N-(3-chlorophenyl)-2-[4-(4-fluorophenyl)piperazin-1-yl] N-(3-chlorophenyl)-2-[4-(4-fluorophenyl)piperazin-1-yl] n-(3-chlorophenyl)-2-[4-(4-fluorophenyl)piperazin-1-yl] N N- N-( N-(3 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 7 -(-)--[-(-)--] 14 8 0 0 0 0 1
acetamide monohydrochloride acetamide a ac ace acet BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 () 2 7 0 0 0 0 1
crystals; mp. crystals; c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 ;.-;:.; 7 8 0 0 0 0 1
NMR (300 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 (,-):.-.(,,- 12 8 0 0 0 0 1
azine), 4.32 azine), a az azi azin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 ),.(,,--),.-.(,,),. 19 9 0 0 0 0 1
(t, 2H, (t, ( (t (t, (t, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 7 (,,,.),.-.(,,), 15 7 0 0 0 0 1
7.84-7.87 (m, 7.84-7.87 7 7. 7.8 7.84 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 7 .-.(,,),.(,,),.(, 17 8 0 0 0 0 1
1H, ?NH); 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 7 ,?);(,-):. 10 7 0 0 0 0 1
(-CH 2 (-ch ( (- (-C (-CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 (--),.(--),.(--),.(--),. 24 10 0 0 0 0 1
(-CH 2 (-ch ( (- (-C (-CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 (--),.,.,.,.,.,.,., 19 9 0 0 0 0 1
134.6, 140.1, 134.6, 1 13 134 134. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 7 .,.,.(),.(--); 14 9 0 0 0 0 1
(282 MHz, (282 ( (2 (28 (282 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 7 (,-):-.(,).-:. 14 8 0 0 0 0 1
(C 18 (c ( (C (C (C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 ([?]?)..- 9 9 0 0 0 0 1
FN 3 fn F FN FN FN BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 (.):,.;,.;,..:, 15 8 0 0 0 0 1
56.35; H, 56.35; 5 56 56. 56.3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 7 .;,.;,.. 8 4 0 0 0 0 1
N-(3-chlorophenyl)-2-[4-[3-(trifluoromethyl)phenyl]piper- N-(3-chlorophenyl)-2-[4-[3-(trifluoromethyl)phenyl]piper- n-(3-chlorophenyl)-2-[4-[3-(trifluoromethyl)phenyl]piper- N N- N-( N-(3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 -(-)--[-[-()]- 14 8 0 0 0 0 1
azin-1-yl]acetamide monohydrochloride azin-1-yl]acetamide a az azi azin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 --]()- 6 8 0 0 0 0 1
dery crystals; dery d de der dery BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 6 8 ;.-;:.; 7 8 0 0 0 0 1
NMR (300 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 8 (,-):.-.(,,- 12 8 0 0 0 0 1
azine), 3.57-3.70 azine), a az azi azin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 8 ),.-.(,,),.-.(,, 16 8 0 0 0 0 1
piperazine), 4.33 piperazine), p pi pip pipe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 8 ),.(,,--),.-.(,,), 18 9 0 0 0 0 1
7.21-7.30 (m, 7.21-7.30 7 7. 7.2 7.21 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 .-.(,,),.-.(,,), 16 7 0 0 0 0 1
7.54-7.60 (m, 7.54-7.60 7 7. 7.5 7.54 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 .-.(,,),.(,,,.), 16 8 0 0 0 0 1
10.95 (brs, 10.95 1 10 10. 10.9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 .(,,),.(,,?); 13 8 0 0 0 0 1
(75 MHz, (75 ( (7 (75 (75 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 (,-):.(--),.(--),. 18 9 0 0 0 0 1
(-CH 2 (-ch ( (- (-C (-CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 8 (--),.(--),.(--),.,.,., 23 9 0 0 0 0 1
119.1, 119.9, 119.1, 1 11 119 119. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 .,.,.,.,.,.,.,., 16 8 0 0 0 0 1
139.9, 141.8 139.9, 1 13 139 139. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 .,.(-,),.(--); 14 9 0 0 0 0 1
(282 MHz, (282 ( (2 (28 (282 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 (,-):-.(,).-:. 14 8 0 0 0 0 1
(C 19 (c ( (C (C (C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 8 ([?]?).. 8 10 0 0 0 0 1
F 3 f F F F F BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 8 (.):,.;,.;,..:, 15 8 0 0 0 0 1
52.68; H, 52.68; 5 52 52. 52.6 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 .;,.;,.. 8 3 0 0 0 0 1
N-(3-chlorophenyl)-2-(4-pyrimidin-2-ylpiperazin-1-yl)ac- N-(3-chlorophenyl)-2-(4-pyrimidin-2-ylpiperazin-1-yl)ac- n-(3-chlorophenyl)-2-(4-pyrimidin-2-ylpiperazin-1-yl)ac- N N- N-( N-(3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 10 -(-)--(-----)- 14 9 0 0 0 0 1
etamide monohydrochloride etamide e et eta etam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 10 ()- 3 8 0 0 0 0 1
tals; mp. tals; t ta tal tals BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 10 ;.-;:.; 7 8 0 0 0 0 1
(300 MHz, (300 ( (3 (30 (300 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 10 (,-):.-.(,,), 13 8 0 0 0 0 1
4.28 (s, 4.28 4 4. 4.2 4.28 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 10 .(,,--),.(,,,.),. 17 9 0 0 0 0 1
(ddd, 1H, (ddd, ( (d (dd (ddd BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 10 (,,,.,.,.),.(,,, 16 9 0 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 10 .),.-.(,,),.(,,, 16 9 0 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 10 .),.-.(,,),.(,, 15 8 0 0 0 0 1
NH), 11.50 nh), N NH NH) NH), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 10 ),.(,,);(,- 11 8 0 0 0 0 1
d 6 d d d d d BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 6 10 ):.(--),.(--),.(--),. 21 10 0 0 0 0 1
3056 3056 3056 3 30 305 3056 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 11 no 0 1 0 1 0 0 0
Med Chem med M Me Med Med BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 11 ():- 4 10 0 1 0 0 0
123 123 123 1 12 123 123 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 11 no 0 10 0 0 0 0 0
(-CH 2 (-ch ( (- (-C (-CH BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 (--),.(--),.,.,.,.,., 21 10 0 1 0 0 1
133.1, 137.8, 133.1, 1 13 133 133. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,.,.,.(),.(--). 16 9 0 1 0 0 1
ESI-MS: 332.7 esi-ms: E ES ESI ESI- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 -:.([?]?).. 11 9 0 1 0 0 1
C 16 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 0 (.):,.;,.;,.. 13 9 0 1 0 0 1
Found: C, found: F Fo Fou Foun BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 :,.;,.;,.. 10 5 0 1 0 0 1
2-(4-Benzylpiperazin-1-yl)-N-(3-chlorophenyl)acetamide 2-(4-Benzylpiperazin-1-yl)-N-(3-chlorophenyl)acetamide 2-(4-benzylpiperazin-1-yl)-n-(3-chlorophenyl)acetamide 2 2- 2-( 2-(4 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 -(---)--(-) 11 8 0 1 0 0 1
dihydrochloride (11) dihydrochloride d di dih dihy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ();. 4 7 0 1 0 0 1
245-247 °C; 245-247 2 24 245 245- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 -;:.;(, 7 8 0 1 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 -):.-.(,,),.(,, 15 9 0 1 0 0 1
-CH 2 -ch - -C -CH -CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 --),.(,,--),.(,,, 17 8 0 1 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 0 .,.,.),.(,,,.), 15 9 0 1 0 0 1
7.41-7.48 (m, 7.41-7.48 7 7. 7.4 7.41 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .-.(,,),.-.(,,), 16 7 0 1 0 0 1
7.60-7.70 (m, 7.60-7.70 7 7. 7.6 7.60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .-.(,,),.(,,,.), 16 8 0 1 0 0 1
9.94 (s, 9.94 9 9. 9.9 9.94 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .(,,),.(,,?),.(,, 17 8 0 1 0 0 1
?NH); 13 ?nh); ? ?N ?NH ?NH) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ?);(,-):.(--), 14 8 0 1 0 0 1
51.5 (-CH 51.5 5 51 51. 51.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .(--),.(--),.(--),.(--), 24 10 0 1 0 0 1
65.7 (-CH 65.7 6 65 65. 65.7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .(--,),.,.,.,.,., 17 9 0 1 0 0 1
130.4, 134.8, 130.4, 1 13 130 130. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,.,.,.(),.(--). 16 9 0 1 0 0 1
ESI-MS: 344.8 esi-ms: E ES ESI ESI- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 -:.([?]?).. 11 9 0 1 0 0 1
C 19 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 0 (.):,.;,.;,.. 13 9 0 1 0 0 1
Found: C, found: F Fo Fou Foun BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 :,.;,.;,.. 10 5 0 1 0 0 1
N-(3-chlorophenyl)-2-(4-methylpiperazin-1-yl)acetamide N-(3-chlorophenyl)-2-(4-methylpiperazin-1-yl)acetamide n-(3-chlorophenyl)-2-(4-methylpiperazin-1-yl)acetamide N N- N-( N-(3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 -(-)--(---) 11 8 0 0 0 0 1
dihydrochloride (12) dihydrochloride d di dih dihy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 2 ();. 4 7 0 0 0 0 1
237-238 °C; 237-238 2 23 237 237- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 -;:.;(, 7 7 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 2 -).(,,),.-.(,,- 15 8 0 0 0 0 1
azine), 4.17 azine), a az azi azin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 2 ),.(,,--),.(,,,., 17 9 0 0 0 0 1
2.12, 0.90 2.12, 2 2. 2.1 2.12 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 .,.),.(,,,.),.(, 16 8 0 0 0 0 1
1H, ArH, 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 ,,.,.,.),.(,,, 14 7 0 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 2 .),.(,,),.(,,?), 16 8 0 0 0 0 1
11.89 (brs, 11.89 1 11 11. 11.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 .(,,?);(,-): 12 8 0 0 0 0 1
32.8 (-CH 32.8 3 32 32. 32.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 .(-),.(--),.(--),.(--), 23 9 0 0 0 0 1
52.6 (-CH 52.6 5 52 52. 52.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 .(--),.(--),.,.,.,., 20 8 0 0 0 0 1
129.8, 137.9 129.8, 1 12 129 129. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 .,.(),.(--).-:. 15 8 0 0 0 0 1
(C 13 (c ( (C (C (C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 2 ([?]?).. 8 10 0 0 0 0 1
(340.68): C, (340.68): ( (3 (34 (340 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 (.):,.;,.;,..:,.;, 18 8 0 0 0 0 1
5.99; N, 5.99; 5 5. 5.9 5.99 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 .;,.. 5 2 0 0 0 0 1
N-(3-chlorophenyl)-2-morpholino-acetamide monohydrochlo- n-(3-chlorophenyl)-2-morpholino-acetamide N N- N-( N-(3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 -(-)---- 8 8 0 0 0 0 1
ride (13) ride r ri rid ride BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 ();.-; 6 7 0 0 0 0 1
HPLC: R hplc: H HP HPL HPLC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 4 :.;(,-): 8 7 0 0 0 0 1
d 1.59-1.88 d d d d d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 7 4 .-.(,,),.-.(,, 14 7 0 0 0 0 1
morpholine), 4.15 morpholine), m mo mor morp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 4 ),.(,,--),.-.(,,), 18 8 0 0 0 0 1
7.37 (t, 7.37 7 7. 7.3 7.37 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 .(,,,.),.-.(,,), 16 8 0 0 0 0 1
7.82-7.86 (m, 7.82-7.86 7 7. 7.8 7.82 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 .-.(,,),.(,,),.(, 17 8 0 0 0 0 1
1H, ?NH); 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 ,?);(,-):. 10 6 0 0 0 0 1
(-CH 2 (-ch ( (- (-C (-CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 4 (--),.(--),.(--),.(--),. 24 9 0 0 0 0 1
(-CH 2 (-ch ( (- (-C (-CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 4 (--),.,.,.,.,.,.(), 19 10 0 0 0 0 1
171.5 (-CO-). 171.5 1 17 171 171. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 .(--).-:.([?]?). 16 8 0 0 0 0 1
Anal. Calcd anal. A An Ana Anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 .(.):,.;,.; 11 10 0 0 0 0 1
N, 9.62. n, N N, N, N, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 4 ,..:,.;,.;,.. 13 6 0 0 0 0 1
2-(4-Phenylpiperazin-1-yl)-N-[3-(trifluoromethyl)phenyl] 2-(4-Phenylpiperazin-1-yl)-N-[3-(trifluoromethyl)phenyl] 2-(4-phenylpiperazin-1-yl)-n-[3-(trifluoromethyl)phenyl] 2 2- 2-( 2-(4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 -(---)--[-()] 13 8 0 1 0 0 1
acetamide (14) acetamide a ac ace acet BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 ();.-; 6 8 0 1 0 0 1
HPLC: R hplc: H HP HPL HPLC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 :.;(,):. 8 8 0 1 0 0 1
(t, 4H, (t, ( (t (t, (t, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 (,,,.),.(,,--),. 16 9 0 1 0 0 1
(t, 4H, (t, ( (t (t, (t, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 (,,,.),.-.(,,), 15 8 0 1 0 0 1
7.25-7.32 (m, 7.25-7.32 7 7. 7.2 7.25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .-.(,,),.(,,,.), 16 8 0 1 0 0 1
7.46 (t, 7.46 7 7. 7.4 7.46 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .(,,,.),.(,,),.(,, 18 9 0 1 0 0 1
NH); 13 nh); N NH NH) NH); BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 );(,):.(--),. 13 8 0 1 0 0 1
(-CH 2 (-ch ( (- (-C (-CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 (--),.(--),.(--),.(--),., 25 9 0 1 0 0 1
116.1, 117.5, 116.1, 1 11 116 116. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,.,.,.,.,.,.,.,. 17 9 0 1 0 0 1
(-CF 3 (-cf ( (- (-C (-CF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 (-,),.(--);(, 13 8 0 1 0 0 1
CDCl 3 cdcl C CD CDC CDCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 ):-.(,).-:.( 12 9 0 1 0 0 1
[M?H] ? [m?h] [ [M [M? [M?H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 [?]?)..(.):,.; 14 10 0 1 0 0 1
H, 5.55; h, H H, H, H, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 ,.;,..:,.;,.;,.. 16 8 0 1 0 0 1
2-[4-(2-Chlorophenyl)piperazin-1-yl]-N-[3-(trifluoromethyl) 2-[4-(2-Chlorophenyl)piperazin-1-yl]-N-[3-(trifluoromethyl) 2-[4-(2-chlorophenyl)piperazin-1-yl]-n-[3-(trifluoromethyl) 2 2- 2-[ 2-[4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 -[-(-)--]--[-() 15 9 0 0 0 0 1
phenyl]acetamide monohydrochloride phenyl]acetamide p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 7 ]()- 4 7 0 0 0 0 1
dery crystals; dery d de der dery BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 7 7 ;.-;:.; 7 8 0 0 0 0 1
NMR (300 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 (,-):.-.(,,- 12 8 0 0 0 0 1
azine), 4.33 azine), a az azi azin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 7 ),.(,,--),.(,,, 15 7 0 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 7 .),.(,,,.),.(,, 15 9 0 0 0 0 1
ArH, J arh, A Ar ArH ArH, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 ,,),.(,,,.),. 13 8 0 0 0 0 1
(t, 1H, (t, ( (t (t, (t, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 7 (,,,.),.(,,, 12 6 0 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 7 .),.(,,),.(,,), 15 8 0 0 0 0 1
11.47 (brs, 11.47 1 11 11. 11.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 .(,,?);(,-): 12 8 0 0 0 0 1
52.6 (-CH 52.6 5 52 52. 52.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 .(--),.(--),.(--),.(--), 24 9 0 0 0 0 1
54.9 (-CH 54.9 5 54 54. 54.9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 .(--),.,.,.,.,.,., 18 8 0 0 0 0 1
123.2, 126.0, 123.2, 1 12 123 123. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 .,.,.,.,.,.,.(-, 16 8 0 0 0 0 1
12C aromatic 12c 1 12 12C 12C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 ),.(--);(,- 11 8 0 0 0 0 1
d 6 d d d d d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 7 7 ):-.(,).-:.( 12 9 0 0 0 0 1
[M?H] ? [m?h] [ [M [M? [M?H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 7 [?]?)..(.):, 12 10 0 0 0 0 1
52.55; H, 52.55; 5 52 52. 52.5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 7 .;,.;,..:,.;,.;,.. 18 9 0 0 0 0 1
2-[4-(4-Chlorophenyl)piperazin-1-yl]-N-[3-(trifluoromethyl) 2-[4-(4-Chlorophenyl)piperazin-1-yl]-N-[3-(trifluoromethyl) 2-[4-(4-chlorophenyl)piperazin-1-yl]-n-[3-(trifluoromethyl) 2 2- 2-[ 2-[4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 -[-(-)--]--[-() 15 9 0 0 0 0 1
phenyl]acetamide (16) phenyl]acetamide p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 9 ]();. 5 7 0 0 0 0 1
170-171 °C; 170-171 1 17 170 170- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 -;:.;(, 7 8 0 0 0 0 1
CDCl 3 cdcl C CD CDC CDCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 9 ):.(,,,.),.(, 13 9 0 0 0 0 1
2H, -CH 2h, 2 2H 2H, 2H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 ,--),.(,,,.) 12 8 0 0 0 0 1
6.83-6.89 (m, 6.83-6.89 6 6. 6.8 6.83 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .-.(,,),.-.(,,),.(, 19 8 0 0 0 0 1
1H, ArH, 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 ,,.),.(,,,.), 13 8 0 0 0 0 1
7.81 (s, 7.81 7 7. 7.8 7.81 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(,,),.(,,);(, 14 8 0 0 0 0 1
CDCl 3 cdcl C CD CDC CDCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 9 ):.(--),.(--),.(--),. 21 10 0 0 0 0 1
0 (-CH 0 0 0 0 0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 9 (--),.(--),.,.,.,., 19 8 0 0 0 0 1
119.8, 124.5, 119.8, 1 11 119 119. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .,.,.,.,.,.,.(-, 16 8 0 0 0 0 1
12C aromatic 12c 1 12 12C 12C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 ),.(--);(,): 12 9 0 0 0 0 1
d -62.74 d d d d d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 7 9 -.(,).-:.( 10 8 0 0 0 0 1
[M?H] ? [m?h] [ [M [M? [M?H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 9 [?]?)..(.): 11 9 0 0 0 0 1
C, 57.36; c, C C, C, C, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 9 ,.;,.;,..:,.;,.;, 17 9 0 0 0 0 1
10.63. 10.63. 10.63. 1 10 10. 10.6 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .. 2 1 0 0 0 0 1
2-[4-(2,3-Dichlorophenyl)piperazin-1-yl]-N-[3-(trifluoromethyl) 2-[4-(2,3-Dichlorophenyl)piperazin-1-yl]-N-[3-(trifluoromethyl) 2-[4-(2,3-dichlorophenyl)piperazin-1-yl]-n-[3-(trifluoromethyl) 2 2- 2-[ 2-[4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 11 -[-(,-)--]--[-() 16 10 0 0 0 0 1
phenyl]acetamide (17) phenyl]acetamide p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 11 ]();. 5 7 0 0 0 0 1
174-175 °C; 174-175 1 17 174 174- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 11 -;:.;(, 7 8 0 0 0 0 1
Med Chem med M Me Med Med BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 11 ():- 4 10 0 1 0 0 0
3057 3057 3057 3 30 305 3057 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 11 no 0 1 0 1 0 0 0
123 123 123 1 12 123 123 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 11 no 0 10 0 0 0 0 0
CDCl 3 cdcl C CD CDC CDCl BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ):.(,,,.),.(, 13 8 0 1 0 0 1
4H, piperazine, 4h, 4 4H 4H, 4H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ,,.),.(,,--), 13 7 0 1 0 0 1
6.98-7.02 (m, 6.98-7.02 6 6. 6.9 6.98 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .-.(,,),.-.(,,),.(, 19 8 0 1 0 0 1
1H, ArH, 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ,,.),.(,,,.), 13 8 0 1 0 0 1
7.79 (s, 7.79 7 7. 7.7 7.79 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .(,,),.(,,,.),. 15 8 0 1 0 0 1
(brs, 1H, (brs, ( (b (br (brs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (,,);(,):.(-- 13 8 0 1 0 0 1
), 54.0 ), ) ), ), ), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ),.(--),.(--),.(--),.(-- 24 9 0 1 0 0 1
), 115.8, ), ) ), ), ), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ),.,.,.,.,.,.,.,., 18 8 0 1 0 0 1
129.5, 131.8, 129.5, 1 12 129 129. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,.,.,.,.(-,),. 15 9 0 1 0 0 1
(-CO-); 19 (-co-); ( (- (-C (-CO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 (--);(,):-.(,). 15 8 0 1 0 0 1
ESI-MS: 432.1 esi-ms: E ES ESI ESI- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 -:.([?]?).. 11 9 0 1 0 0 1
for C for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 (.):,.;,.;,.. 13 10 0 1 0 0 1
Found: C, found: F Fo Fou Foun BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 :,.;,.;,.. 10 5 0 1 0 0 1
2-[4-(2-Fluorophenyl)piperazin-1-yl]-N-[3-(trifluoromethyl) 2-[4-(2-Fluorophenyl)piperazin-1-yl]-N-[3-(trifluoromethyl) 2-[4-(2-fluorophenyl)piperazin-1-yl]-n-[3-(trifluoromethyl) 2 2- 2-[ 2-[4 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 -[-(-)--]--[-() 15 9 0 0 0 0 1
phenyl]acetamide monohydrochloride phenyl]acetamide p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 ]()- 4 8 0 0 0 0 1
dery crystals; dery d de der dery BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 8 1 ;.-;:.; 7 9 0 0 0 0 1
NMR (300 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 1 (,-):.-.(,,- 12 8 0 0 0 0 1
azine), 4.30 azine), a az azi azin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 ),.(,,--),.-.(,,),. 19 9 0 0 0 0 1
(d, 1H, (d, ( (d (d, (d, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 (,,,.),.(,,, 12 7 0 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 1 .),.(,,,.),.(, 14 9 0 0 0 0 1
1H, NH), 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 ,),,(,,?);(, 12 7 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 1 -):.(--),.(--),.(--), 21 10 0 0 0 0 1
54.4 (-CH 54.4 5 54 54. 54.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 .(--),.(--),.,.,.,., 20 9 0 0 0 0 1
117.0, 119.8, 117.0, 1 11 117 117. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 .,.,.,.,.,.,.,., 16 9 0 0 0 0 1
147.1 (-CF 147.1 1 14 147 147. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 .(-,),.(--); 12 8 0 0 0 0 1
(282 MHz, (282 ( (2 (28 (282 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 (,-):-.-(-.)(,), 16 8 0 0 0 0 1
-61.43 (s, -61.43 - -6 -61 -61. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 -.(,).-:.([?]?). 16 10 0 0 0 0 1
Anal. Calcd anal. A An Ana Anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 1 .(.):,.;, 9 9 0 0 0 0 1
4.82; N. 4.82; 4 4. 4.8 4.82 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 .;...:,.;,.;,.. 15 8 0 0 0 0 1
2-[4-(4-Fluorophenyl)piperazin-1-yl]-N-[3-(trifluoromethyl) 2-[4-(4-Fluorophenyl)piperazin-1-yl]-N-[3-(trifluoromethyl) 2-[4-(4-fluorophenyl)piperazin-1-yl]-n-[3-(trifluoromethyl) 2 2- 2-[ 2-[4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 -[-(-)--]--[-() 15 9 0 0 0 0 1
phenyl]acetamide monohydrochloride phenyl]acetamide p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 3 ]()- 4 7 0 0 0 0 1
dery crystals; dery d de der dery BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 8 3 ;.-;:.; 7 9 0 0 0 0 1
NMR (300 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 3 (,-):.-.(,,- 12 8 0 0 0 0 1
azine), 4.32 azine), a az azi azin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 3 ),.(,,--),.-.(,,),. 19 9 0 0 0 0 1
(d, 1H, (d, ( (d (d, (d, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 3 (,,,.),.(,,, 12 7 0 0 0 0 1
J = j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 3 .),.(,,,.),.(,, 15 9 0 0 0 0 1
ArH), 10,72 arh), A Ar ArH ArH) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 3 ),,(,,),,(,,?); 15 8 0 0 0 0 1
(75 MHz, (75 ( (7 (75 (75 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 (,-):.(--),.(--),. 18 9 0 0 0 0 1
(-CH 2 (-ch ( (- (-C (-CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 3 (--),.(--),.(--),.,.,., 23 10 0 0 0 0 1
118.6, 120.7, 118.6, 1 11 118 118. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 .,.,.,.,.,.,.,. 15 8 0 0 0 0 1
(-CF 3 (-cf ( (- (-C (-CF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 3 (-,),.(--);(, 13 9 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 3 -):-.(,),-.(,).-: 17 8 0 0 0 0 1
381.8 (C 381.8 3 38 381 381. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 .([?]?).. 9 10 0 0 0 0 1
ClF 4 clf C Cl ClF ClF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 3 (.):,.;,.;,..:, 15 9 0 0 0 0 1
54.67;, 4.93; 54.67;, 5 54 54. 54.6 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 3 .;,.;,.. 8 3 0 0 0 0 1
N-[3-(Trifluoromethyl)phenyl]-2-[4-[3-(trifluoromethyl) N-[3-(Trifluoromethyl)phenyl]-2-[4-[3-(trifluoromethyl) n-[3-(trifluoromethyl)phenyl]-2-[4-[3-(trifluoromethyl) N N- N-[ N-[3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 -[-()]--[-[-() 14 10 0 0 0 0 1
phenyl]piperazin-1-yl]acetamide phenyl]piperazin-1-yl]acetamide phenyl]piperazin-1-yl]acetamide p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 ]--] 4 5 0 0 0 0 1
monohydrochloride monohydrochloride monohydrochloride m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 no 0 3 0 0 0 0 1
(20) White (20) ( (2 (20 (20) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 ();.-;: 7 9 0 0 0 0 1
R t r R R R R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 5 .;(,-): 7 8 0 0 0 0 1
3.13-3.69 (m, 3.13-3.69 3 3. 3.1 3.13 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .-.(,,),.(,,--), 16 9 0 0 0 0 1
7.10-7.18 (m, 7.10-7.18 7 7. 7.1 7.10 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .-.(,,),.-.(,,), 16 8 0 0 0 0 1
7.32-7.49 (m, 7.32-7.49 7 7. 7.3 7.32 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .-.(,,),.-.(,,),.(, 19 8 0 1 0 0 1
1H, ArH, 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 ,,.),.(,,),.(, 14 8 0 1 0 0 1
1H, ?NH); 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 ,?);(,-):.(-- 13 7 0 1 0 0 1
), 52.9 ), ) ), ), ), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 ),.(--),.(--),.(--),.(-- 24 9 0 1 0 0 1
), 115.2, ), ) ), ), ), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 ),.,.,.,.,.,.,.,., 18 8 0 1 0 0 1
126.3, 129.8, 126.3, 1 12 126 126. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,.,.,.,.,.(-,-, 16 8 0 1 0 0 1
12C aromatic 12c 1 12 12C 12C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 ),.(--);(,- 11 7 0 1 0 0 1
d 6 d d d d d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 8 5 ):-.(,),-.(,).-:. 17 7 0 1 0 0 1
(C 20 (c ( (C (C (C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 ([?]?).. 8 10 0 1 0 0 1
(467.84): C, (467.84): ( (4 (46 (467 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 (.):,.;,.;,..:,.;, 18 8 0 1 0 0 1
4.44; N, 4.44; 4 4. 4.4 4.44 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .;,.. 5 2 0 1 0 0 1
2-(4-Pyrimidin-2-ylpiperazin-1-yl)-N-[3-(trifluoromethyl) 2-(4-Pyrimidin-2-ylpiperazin-1-yl)-N-[3-(trifluoromethyl) 2-(4-pyrimidin-2-ylpiperazin-1-yl)-n-[3-(trifluoromethyl) 2 2- 2-( 2-(4 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 -(-----)--[-() 14 8 0 0 0 0 1
phenyl]acetamide monohydrochloride phenyl]acetamide p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 ]()- 4 7 0 0 0 0 1
dery crystals; dery d de der dery BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 9 7 ;.-;:.; 7 8 0 0 0 0 1
NMR (300 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 7 (,-):.-.(,,- 12 8 0 0 0 0 1
azine), 4.26 azine), a az azi azin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 ),.(,,--),.(,,, 15 8 0 0 0 0 1
4.87 Hz), 4.87 4 4. 4.8 4.87 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 .),.(,,,.),.(,, 15 8 0 0 0 0 1
ArH, J arh, A Ar ArH ArH, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 7 ,.),.-.(,,),.(,, 16 8 0 0 0 0 1
ArH), 8.44 arh), A Ar ArH ArH) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 7 ),.(,,,.),.(,,), 16 8 0 0 0 0 1
11.26 (brs, 11.26 1 11 11. 11.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 .(,,?);(,-): 12 8 0 0 0 0 1
51.4 (-CH 51.4 5 51 51. 51.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 .(--),.(--),.(--),.(--), 24 9 0 0 0 0 1
55.2 (-CH 55.2 5 55 55. 55.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 .(--),.,.,.,.,.,., 18 8 0 0 0 0 1
132.6, 139.8, 132.6, 1 13 132 132. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 .,.,.,.(-,),. 13 8 0 0 0 0 1
(-CO-); 19 (-co-); ( (- (-C (-CO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 7 (--);(,-):-.(, 14 8 0 0 0 0 1
3F). ESI-MS: 3f). 3 3F 3F) 3F). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 ).-:.([?]?).. 13 9 0 0 0 0 1
for C for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 7 (.):,.;,.;,.. 13 10 0 0 0 0 1
Found: C, found: F Fo Fou Foun BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 7 :,.;,.;,.. 10 5 0 0 0 0 1
2-(4-Benzylpiperazin-1-yl)-N-[3-(trifluoromethyl)phenyl] 2-(4-Benzylpiperazin-1-yl)-N-[3-(trifluoromethyl)phenyl] 2-(4-benzylpiperazin-1-yl)-n-[3-(trifluoromethyl)phenyl] 2 2- 2-( 2-(4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 9 -(---)--[-()] 13 8 0 0 0 0 1
acetamide acetamide acetamide a ac ace acet BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 9 no 0 1 0 0 0 0 1
(22) White (22) ( (2 (22 (22) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 9 () 2 1 0 0 0 0 1
powdery powdery powdery p po pow powd BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 no 0 1 0 0 0 0 1
crystals; crystals; crystals; c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 ; 1 1 0 0 0 0 1
mp. mp. mp. m mp mp. mp. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 9 . 1 0 0 0 0 0 1
115-116 °C; 115-116 1 11 115 115- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 9 -;:.;(, 7 8 0 0 0 0 1
CDCl 3 cdcl C CD CDC CDCl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 9 ):.-.(,,),.(,, 14 8 0 0 0 0 1
-CH 2 -ch - -C -CH -CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 9 --),.(,,--),.-.(,,), 20 8 0 0 0 0 1
7.45 (t, 7.45 7 7. 7.4 7.45 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 9 .(,,,.),.-.(,,), 16 8 0 0 0 0 1
9.29 (s, 9.29 9 9. 9.2 9.29 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 9 .(,,);(,):. 11 8 0 0 0 0 1
(-CH 2 (-ch ( (- (-C (-CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 9 (--),.(--),.(--),.(--),. 24 9 0 0 0 0 1
(-CH 2 (-ch ( (- (-C (-CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 9 (--),.(--),.,.,.,.,., 21 9 0 0 0 0 1
128.9, 130.9, 128.9, 1 12 128 128. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 9 .,.,.,.,.(-,),. 15 10 0 0 0 0 1
(-CO-); 19 (-co-); ( (- (-C (-CO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 9 (--);(,):-.(,). 15 8 0 0 0 0 1
ESI-MS: 378.4 esi-ms: E ES ESI ESI- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 9 -:.([?]?).. 11 9 0 0 0 0 1
C 20 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 9 (.):,.;,.;,.. 13 9 0 0 0 0 1
Found: C, found: F Fo Fou Foun BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 9 :,.;,.;,.. 10 5 0 0 0 0 1
2-[4-(2-Hydroxyethyl)piperazin-1-yl]-N-[3-(trifluoromethyl) 2-[4-(2-Hydroxyethyl)piperazin-1-yl]-N-[3-(trifluoromethyl) 2-[4-(2-hydroxyethyl)piperazin-1-yl]-n-[3-(trifluoromethyl) 2 2- 2-[ 2-[4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 -[-(-)--]--[-() 15 10 0 0 0 0 1
phenyl]acetamide dihydrochloride phenyl]acetamide p ph phe phen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 10 ]() 3 8 0 0 0 0 1
crystals; mp. crystals; c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 ;.-;:.; 7 8 0 0 0 0 1
NMR (300 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 10 (,-):.-.(,;: 12 8 0 0 0 0 1
piperazine, 4H: piperazine, p pi pip pipe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 10 ,:--,:--,:-),.(, 16 9 0 0 0 0 1
2H, ArH, 2h, 2 2H 2H, 2H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 ,,.),.(,,,.), 13 9 0 0 0 0 1
7.84 (d, 7.84 7 7. 7.8 7.84 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 .(,,,,),.(,,),. 15 9 0 0 0 0 1
(brs, 1H, (brs, ( (b (br (brs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 10 (,,?),.(,,?); 13 7 0 0 0 0 1
(75 MHz, (75 ( (7 (75 (75 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 (,-):.(--),.(--),. 18 10 0 0 0 0 1
(-CH 2 (-ch ( (- (-C (-CH BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 10 (--),.(--),.(--),.(--), 23 9 0 0 0 0 1
3058 3058 3058 3 30 305 3058 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 11 no 0 1 0 1 0 0 0
Med Chem med M Me Med Med BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 ():- 4 10 0 1 0 0 0
123 123 123 1 12 123 123 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 11 no 0 10 0 0 0 0 0
118.7, 119.6, 118.7, 1 11 118 118. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,.,.,.,.,.,.(-, 16 8 0 1 0 0 1
6C aromatic 6c 6 6C 6C 6C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ),.(--);(,- 11 7 0 1 0 0 1
d 6 d d d d d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 9 0 ):-.(,).-:.( 12 9 0 1 0 0 1
[M?H] ? [m?h] [ [M [M? [M?H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 [?]?)..(.):, 12 10 0 1 0 0 1
44.57; H, 44.57; 4 44 44. 44.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .;,.;,..:,.;,.;, 16 8 0 1 0 0 1
10.48. 10.48. 10.48. 1 10 10. 10.4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .. 2 1 0 1 0 0 1
2-Morpholino-N-[3-(trifluoromethyl)phenyl]acetamide 2-Morpholino-N-[3-(trifluoromethyl)phenyl]acetamide 2-morpholino-n-[3-(trifluoromethyl)phenyl]acetamide 2 2- 2-M 2-Mo BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 ---[-()] 8 7 0 0 0 0 1
monohydrochloride (24) monohydrochloride m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 ();. 4 7 0 0 0 0 1
185-186 °C; 185-186 1 18 185 185- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 -;:.;(, 7 8 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 1 -):.-.(,,),.-. 14 8 0 0 0 0 1
(m, 4H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 (,,),.(,,--),.(,, 17 8 0 0 0 0 1
ArH, J arh, A Ar ArH ArH, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 1 ,.),.(,,,.),. 13 8 0 0 0 0 1
(d, 1H, (d, ( (d (d, (d, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 (,,,.),.(,,),.(, 16 8 0 0 0 0 1
1H, NH), 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 ,),.(,,?);(, 12 7 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 1 -):.(--),.(--),.(--), 21 9 0 0 0 0 1
67.5 (-CH 67.5 6 67 67. 67.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 .(--),.(--),.,.,.,., 20 9 0 0 0 0 1
125.8, 133.4, 125.8, 1 12 125 125. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 .,.,.(-,),.(--); 16 9 0 0 0 0 1
NMR (282 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 1 (,-):-.(,).-: 13 7 0 0 0 0 1
289.2 (C 289.2 2 28 289 289. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 .([?]?).. 9 10 0 0 0 0 1
ClF 3 clf C Cl ClF ClF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 1 (.):,.;,.;,..:, 15 9 0 0 0 0 1
48.20; H, 48.20; 4 48 48. 48.2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 .;,.;,.. 8 3 0 0 0 0 1
Pharmacology Pharmacology pharmacology P Ph Pha Phar BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 no 0 10 0 0 0 0 1
In vivo in I In In In BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 10 4 no 0 10 0 0 0 0 1
Compounds 3-24 compounds C Co Com Comp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 - 1 7 0 0 0 0 1
within the within w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 ()- 3 7 0 0 0 0 1
gram in gram g gr gra gram BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 ,, 2 8 0 0 0 0 1
National Institute national N Na Nat Nati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 no 0 8 0 0 0 0 1
Disorders and disorders D Di Dis Diso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 (/),,,, 7 8 0 0 0 0 1
by using by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 (., 3 8 0 0 0 0 1
1978; Kupferberg, 1978; 1 19 197 1978 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 4 ;,). 4 3 0 0 0 0 1
Phase I phase P Ph Pha Phas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 :, 2 8 0 0 0 0 1
scPTZ and scptz s sc scP scPT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 .(#, 4 9 0 0 0 0 1
weighing 18-25 weighing w we wei weig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 -)(-) 5 8 0 0 0 0 1
were used were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 . 1 8 0 0 0 0 1
in metabolic in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 4 . 1 9 0 0 0 0 1
The compounds the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 no 0 8 0 0 0 0 1
suspension in suspension s su sus susp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 ./ 2 8 0 0 0 0 1
level 30, level l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 ,/ 2 8 0 0 0 0 1
neurotoxicity assessment neurotoxicity n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 .. 2 9 0 0 0 0 1
Promising derivatives promising P Pr Pro Prom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 no 0 8 0 0 0 0 1
which they which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 no 0 9 0 0 0 0 1
of 30 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 /- 2 8 0 0 0 0 1
nation at nation n na nat nati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 4 :.,.,,,. 8 10 0 0 0 0 1
eight mice eight e ei eig eigh BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 . 1 5 0 0 0 0 1
Maximal electroshock maximal M Ma Max Maxi BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 () 2 10 0 1 0 0 1
In the in I In In In BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 10 6 ,.- 3 9 0 1 0 0 1
ration (50 ration r ra rat rati BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 () 2 10 0 1 0 0 1
corneal electrodes corneal c co cor corn BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 7 no 0 9 0 1 0 0 1
containing an containing c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 . 1 10 0 1 0 0 1
extension of extension e ex ext exte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 ., 2 9 0 1 0 0 1
procedures cause procedures p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 . 1 9 0 1 0 0 1
Mice not mice M Mi Mic Mice BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 7 - 1 9 0 1 0 0 1
ered to ered e er ere ered BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 7 . 1 6 0 1 0 0 1
Subcutaneous pentylenetetrazole subcutaneous S Su Sub Subc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 7 () 2 10 0 0 0 0 1
The scPTZ the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 7 no 0 8 0 0 0 0 1
(85 mg/kg (85 ( (8 (85 (85 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 (/) 3 9 0 0 0 0 1
a period a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 10 7 (). 3 9 0 0 0 0 1
PTZ is ptz P PT PTZ PTZ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 7 . 1 9 0 0 0 0 1
compounds, and compounds, c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 ,. 2 9 0 0 0 0 1
the control the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 , 1 10 0 0 0 0 1
observed between observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 .- 2 8 0 0 0 0 1
sence of sence s se sen senc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 7 no 0 9 0 0 0 0 1
0.5 and 0.5 0 0. 0.5 0.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 .' 2 8 0 0 0 0 1
protect against protect p pr pro prot BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 7 -. 2 6 0 0 0 0 1
Neurotoxicity screening neurotoxicity N Ne Neu Neur BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 8 no 0 10 0 0 0 0 1
The neurological the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 8 () 2 9 0 0 0 0 1
was detected was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 no 0 10 0 0 0 0 1
(Dunham and (dunham ( (D (Du (Dun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 8 (,)., 5 9 0 0 0 0 1
when placed when w wh whe when BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 , 1 10 0 0 0 0 1
a prolonged a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 10 8 . 1 9 0 0 0 0 1
demonstrated by demonstrated d de dem demo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 no 0 9 0 0 0 0 1
equilibrium for equilibrium e eq equ equi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 . 1 9 0 0 0 0 1
The psychomotor the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 9 - 1 10 0 0 0 0 1
The 6-Hz the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 9 - 1 9 0 0 0 0 1
that uses that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 -(),-()- 8 9 0 0 0 0 1
trical stimulation. trical t tr tri tric BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 9 .(. 3 9 0 0 0 0 1
monopolar rectangular monopolar m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 9 -)- 3 9 0 0 0 0 1
ered by ered e er ere ered BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 9 -., 3 9 0 0 0 0 1
mice were mice m mi mic mice BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 - 1 9 0 0 0 0 1
servation cage servation s se ser serv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 9 . 1 9 0 0 0 0 1
The seizures the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 9 '''' 4 10 0 0 0 0 1
rearing, forelimb, rearing, r re rea rear BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 ,,, 3 8 0 0 0 0 1
twitching the twitching t tw twi twit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 -. 2 10 0 0 0 0 1
seizure activity seizure s se sei seiz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 - 1 9 0 0 0 0 1
mals. At mals. m ma mal mals BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 9 .,- 3 9 0 0 0 0 1
mal exploratory mal m ma mal mal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 9 . 1 9 0 0 0 0 1
protection against protection p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 . 1 9 0 0 0 0 1
be protected be b be be be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 no 0 9 0 0 0 0 1
within 10 within w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 (.,). 5 9 0 0 0 0 1
In vitro in I In In In BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 10 11 - 1 10 0 1 0 0 1
The radioligand the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 11 - 1 8 0 1 0 0 1
cially in cially c ci cia cial BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 11 (,) 3 10 0 1 0 0 1
Med Chem med M Me Med Med BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 11 ():- 4 10 0 1 0 0 0
3059 3059 3059 3 30 305 3059 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 11 no 0 1 0 1 0 0 0
123 123 123 1 12 123 123 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 11 no 0 10 0 1 0 0 0
procedures described procedures p pr pro proc BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 (,). 4 10 0 1 0 0 1
The general the T Th The The BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 . 1 8 0 1 0 0 1
Conclusion Conclusion conclusion C Co Con Conc BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 10 0 1 0 0 1
In the in I In In In BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 10 0 ,- 2 8 0 1 0 0 1
N-phenyl-2-(4-phenylpiperazin-1-yl)acetamide derivatives n-phenyl-2-(4-phenylpiperazin-1-yl)acetamide N N- N-p N-ph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ---(---) 8 9 0 1 0 0 1
has been has h ha has has BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 9 0 1 0 0 1
activity in activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 () 2 8 0 1 0 0 1
seizure tests. seizure s se sei seiz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 . 1 10 0 1 0 0 1
showed activity showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 9 0 1 0 0 1
for 3-(trifluoromethyl)anilide for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -(), 4 9 0 1 0 0 1
of 3-chloroanilide of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -.- 3 8 0 1 0 0 1
cules showed cules c cu cul cule BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 - 1 9 0 1 0 0 1
their potential their t th the thei BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 - 1 9 0 1 0 0 1
epilepsy. The epilepsy. e ep epi epil BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .-,- 4 9 0 1 0 0 1
dione ring dione d di dio dion BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 10 0 . 1 8 0 1 0 0 1
Acknowledgments The acknowledgments A Ac Ack Ackn BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 1 no 0 8 0 0 0 0 1
Drug Development drug D Dr Dru Drug BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 1 (, 2 9 0 0 0 0 1
Neurological Disorders neurological N Ne Neu Neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 1 ,, 2 9 0 0 0 0 1
Rockville, MD, rockville, R Ro Roc Rock BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 1 ,,),. 5 10 0 0 0 0 1
to Professor to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 -(- 3 8 0 0 0 0 1
nology and nology n no nol nolo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 1 , 1 9 0 0 0 0 1
College, Krako college, C Co Col Coll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 1 ,,) 3 9 0 0 0 0 1
Polish site polish P Po Pol Poli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 1 . 1 9 0 0 0 0 1
compounds. compounds. compounds. c co com comp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 . 1 1 0 0 0 0 1
Conflict of conflict C Co Con Conf BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 2 . 1 10 0 0 0 0 1
Open Access open O Op Ope Open BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 2 no 0 9 0 0 0 0 1
Creative Commons creative C Cr Cre Crea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 2 , 1 8 0 0 0 0 1
distribution, and distribution, d di dis dist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 ,, 2 10 0 0 0 0 1
author(s) and author(s) a au aut auth BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 2 (). 3 5 0 0 0 0 1
References References references R Re Ref Refe BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 2 no 0 10 0 0 0 0 1
Barton ME, barton B Ba Bar Bart BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 2 ,,,() 5 9 0 0 0 0 1
characterization of characterization c ch cha char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 no 0 8 0 0 0 0 1
partial epilepsy. partial p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 .():- 5 6 0 0 0 0 1
Beguin C, beguin B Be Beg Begu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 2 ,,,,, 5 8 0 0 0 0 1
(2003) Functionalized (2003) ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 2 (): 3 8 0 0 0 0 1
agents. Bioorg agents. a ag age agen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 .():- 5 6 0 0 0 0 1
Bell GS, bell B Be Bel Bell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 10 2 ,(): 4 10 0 0 0 0 1
the problem. the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 .():- 5 6 0 0 0 0 1
Bialer M, bialer B Bi Bia Bial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 2 ,,,,, 5 8 0 0 0 0 1
Tomson T tomson T To Tom Toms BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 2 (): 3 9 0 0 0 0 1
summary of summary s su sum summ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 (). 3 8 0 0 0 0 1
Res 73(1):1-52 res R Re Res Res BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 2 ():- 4 2 0 0 0 0 1
Bialer M, bialer B Bi Bia Bial BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 2 ,,,,, 5 9 0 0 0 0 1
(2009) Progress (2009) ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 2 (): 3 9 0 0 0 0 1
the ninth the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 2 ().():- 7 9 0 0 0 0 1
Brown GB brown B Br Bro Brow BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 10 4 ()--- 5 9 0 1 0 0 1
sensitive sodium sensitive s se sen sens BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 : 1 8 0 1 0 0 1
tetrodotoxin and tetrodotoxin t te tet tetr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 .():- 5 7 0 1 0 0 1
Brown WC, brown B Br Bro Brow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 10 4 ,,,() 5 7 0 1 0 0 1
Comparative assay comparative C Co Com Comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 no 0 8 0 1 0 0 1
seizure test seizure s se sei seiz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 . 1 9 0 1 0 0 1
Exp Ther exp E Ex Exp Exp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ():- 4 3 0 1 0 0 1
Bruno-Blanch L, bruno-blanch B Br Bru Brun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 -,,-() 6 9 0 1 0 0 1
virtual screening: virtual v vi vir virt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 : 1 8 0 1 0 0 1
chemical diversity. chemical c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 .():- 5 8 0 1 0 0 1
Catterall WA, catterall C Ca Cat Catt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ,,,() 5 8 0 1 0 0 1
batrachotoxinin A batrachotoxinin b ba bat batr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 --- 3 8 0 1 0 0 1
ated with ated a at ate ated BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 . 1 8 0 1 0 0 1
J Biol j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 4 ():- 4 4 0 1 0 0 1
Chang BS, chang C Ch Cha Chan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 4 ,(). 4 7 0 1 0 0 1
349(13):1257-1266 349(13):1257-1266 349(13):1257-1266 3 34 349 349( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 4 ():- 4 2 0 1 0 0 1
Dunham NW, dunham D Du Dun Dunh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 4 ,() 3 8 0 1 0 0 1
detecting neurological detecting d de det dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 . 1 8 0 1 0 0 1
Assoc 46(3):208-209 assoc A As Ass Asso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ():-(.) 7 4 0 1 0 0 1
Ghidini E, ghidini G Gh Ghi Ghid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ,,,,,, 6 9 0 1 0 0 1
Simonato M, simonato S Si Sim Simo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ,,,, 4 8 0 1 0 0 1
M, Villetti m, M M, M, M, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ,() 3 9 0 1 0 0 1
class of class c cl cla clas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 --- 3 8 0 1 0 0 1
derivatives. Bioorg derivatives. d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 .():- 5 6 0 1 0 0 1
Hadjipavlou-Litina D hadjipavlou-litina H Ha Had Hadj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 -(),, 5 9 0 1 0 0 1
quantitative structure-activity quantitative q qu qua quan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 -. 2 9 0 1 0 0 1
Res Rev res R Re Res Res BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ():- 4 2 0 1 0 0 1
Hen H, hen H He Hen Hen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 ,,,,() 6 9 0 1 0 0 1
and evaluation and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 no 0 8 0 1 0 0 1
novel amide novel n no nov nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 no 0 8 0 1 0 0 1
with 4-aminobenzensulfonamide. with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 -.():- 6 8 0 1 0 0 1
Ismail FMD ismail I Is Ism Isma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 4 () 2 9 0 1 0 0 1
clinical use. clinical c cl cli clin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 .(-):- 6 6 0 1 0 0 1
Kamin ´ski kamin K Ka Kam Kami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ,,() 4 10 0 1 0 0 1
activity of activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 -[---(---)]- 12 9 0 1 0 0 1
2,5-diones. Bioorg 2,5-diones. 2 2, 2,5 2,5- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 ,-.():- 7 7 0 1 0 0 1
Kamin ´ski kamin K Ka Kam Kami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ,,,() 5 9 0 1 0 0 1
and anticonvulsant and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 no 0 8 0 1 0 0 1
phthalimide, and phthalimide, p ph pht phth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 , 1 8 0 1 0 0 1
analogs. Eur analogs. a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 .():- 5 5 0 1 0 0 1
Kamin ´ski kamin K Ka Kam Kami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ,,,,() 6 8 0 1 0 0 1
Synthesis and synthesis S Sy Syn Synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 - 1 8 0 1 0 0 1
derived from derived d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 ----,-- 7 8 0 1 0 0 1
Part V. part P Pa Par Part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 .:- 3 4 0 1 0 0 1
Kamin ´ski kamin K Ka Kam Kami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ,,(), 5 9 0 1 0 0 1
properties, and properties, p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 ,- 2 8 0 1 0 0 1
lidine-2,5-diones and lidine-2,5-diones l li lid lidi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 -,--,-. 7 8 0 1 0 0 1
Life Sci life L Li Lif Life BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 :- 2 2 0 1 0 0 1
Khan HN, khan K Kh Kha Khan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 4 ,,() 4 8 0 1 0 0 1
model development model m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 no 0 9 0 1 0 0 1
compound. Epilepsy compound. c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 .():- 5 4 0 1 0 0 1
Kirk KL kirk K Ki Kir Kirk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 4 (): 3 9 0 1 0 0 1
applications of applications a ap app appl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 4 . 1 8 0 1 0 0 1
127(8):1013-1027 127(8):1013-1027 127(8):1013-1027 1 12 127 127( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 4 ():- 4 2 0 1 0 0 1
Krall RL, krall K Kr Kra Kral BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ,,,,() 6 8 0 1 0 0 1
Antiepileptic drug antiepileptic A An Ant Anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 :- 2 8 0 1 0 0 1
ing. Epilepsia ing. i in ing ing. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 .():- 5 4 0 1 0 0 1
Kupferberg HJ kupferberg K Ku Kup Kupf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 (): 3 8 0 1 0 0 1
cooperative effort cooperative c co coo coop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 . 1 8 0 1 0 0 1
30(Suppl. 1):S51-S56 30(suppl. 3 30 30( 30(S BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 (.):- 5 2 0 1 0 0 1
Table 6 table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 -?() 4 10 0 1 0 0 1
Source Source source S So Sou Sour BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 3 0 1 0 0 1
Ligand Ligand ligand L Li Lig Liga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 no 0 3 0 1 0 0 1
Concentration Concentration concentration C Co Con Conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 7 0 1 0 0 1
Kd Kd kd K Kd Kd Kd BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 no 0 1 0 1 0 0 1
Nonspecific binding nonspecific N No Non Nons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 no 0 10 0 1 0 0 1
Incubation Incubation incubation I In Inc Incu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 5 0 1 0 0 1
Detection method detection D De Det Dete BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 8 0 1 0 0 1
Rat cerebral rat R Ra Rat Rat BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 8 0 1 0 0 1
[ 3 [ [ [ [ [ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 11 [] 2 9 0 1 0 0 1
10 nM 10 1 10 10 10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 11 no 0 2 0 1 0 0 1
91 nM 91 9 91 91 91 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 11 no 0 2 0 1 0 0 1
Veratridine (300 veratridine V Ve Ver Vera BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 () 2 9 0 1 0 0 1
60 min 60 6 60 60 60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 11 no 0 5 0 1 0 0 1
Scintillation counting scintillation S Sc Sci Scin BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 no 0 10 0 1 0 0 1
3060 3060 3060 3 30 306 3060 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 11 no 0 1 0 1 0 0 0
Med Chem med M Me Med Med BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 ():- 4 10 0 1 0 0 0
123 123 123 1 12 123 123 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 11 no 0 10 0 0 0 0 0
Liu G, liu L Li Liu Liu BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 0 ,-,,,, 6 9 0 0 0 0 1
WA (2003) wa W WA WA WA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 11 0 () 2 8 0 0 0 0 1
drugs with drugs d dr dru drug BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 - 1 7 0 0 0 0 1
sodium channels. sodium s so sod sodi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ..():- 6 6 0 0 0 0 1
Łuszczki JJ łuszczki Ł Łu Łus Łusz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ()-: 4 9 0 0 0 0 1
of action, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ,. 2 8 0 0 0 0 1
61(2):197-216 61(2):197-216 61(2):197-216 6 61 61( 61(2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ():- 4 1 0 0 0 0 1
Malawska B malawska M Ma Mal Mala BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 (). 3 8 0 0 0 0 1
5(1):69-85 5(1):69-85 5(1):69-85 5 5( 5(1 5(1) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ():- 4 1 0 0 0 0 1
Masereel B, masereel M Ma Mas Mase BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,,,() 6 8 0 0 0 0 1
Carbonic anhydrase carbonic C Ca Car Carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 : 1 8 0 0 0 0 1
incorporating valproyl incorporating i in inc inco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 . 1 8 0 0 0 0 1
Chem 45(2):312-320 chem C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ():- 4 2 0 0 0 0 1
Matsuki N, matsuki M Ma Mat Mats BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,,() 5 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 7 0 0 0 0 1
neuroblastoma cells. neuroblastoma n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 .():- 5 8 0 0 0 0 1
Meldrum BS, meldrum M Me Mel Meld BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 0 ,()- 4 9 0 0 0 0 1
tic drug tic t ti tic tic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .():- 5 7 0 0 0 0 1
Morieux P, morieux M Mo Mor Mori BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,() 4 9 0 0 0 0 1
activities of activities a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 -()----- 8 8 0 0 0 0 1
onamide derivatives. onamide o on ona onam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 .():- 5 7 0 0 0 0 1
Obniska J, obniska O Ob Obn Obni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,() 3 10 0 0 0 0 1
of new of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 -[(---)-]- 10 8 0 0 0 0 1
pyrrolidine-2,5-dione and pyrrolidine-2,5-dione p py pyr pyrr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 -,---[.]-,-. 12 8 0 0 0 0 1
Farmaco 58(12):1227-1234 farmaco F Fa Far Farm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ():- 4 3 0 0 0 0 1
Obniska J, obniska O Ob Obn Obni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,,-, 5 8 0 0 0 0 1
Karolak-Wojciechowska J karolak-wojciechowska K Ka Kar Karo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 -() 3 8 0 0 0 0 1
activity of activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ------ 6 7 0 0 0 0 1
spiro[4.4]nonane-and [4.5]decane-1,3-dione spiro[4.4]nonane-and s sp spi spir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 [.]-[.]-,-: 11 8 0 0 0 0 1
III. J iii. I II III III. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 .():- 5 5 0 0 0 0 1
Obniska J, obniska O Ob Obn Obni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,,,() 6 9 0 0 0 0 1
Synthesis and synthesis S Sy Syn Synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 8 0 0 0 0 1
derived from derived d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ---,-.. 7 8 0 0 0 0 1
343(6):333-341 343(6):333-341 343(6):333-341 3 34 343 343( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ():- 4 2 0 0 0 0 1
Obniska J, obniska O Ob Obn Obni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,,,-() 6 9 0 0 0 0 1
Synthesis and synthesis S Sy Syn Synt BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 - 1 8 0 0 0 0 1
derived from derived d de der deri BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ,------- 8 8 0 0 0 0 1
2,5-diones. Part 2,5-diones. 2 2, 2,5 2,5- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 ,-..():- 8 6 0 0 0 0 1
Rogawski MA rogawski R Ro Rog Roga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 () 2 8 0 0 0 0 1
antiepileptic drug antiepileptic a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 .():- 5 8 0 0 0 0 1
Rogawski MA, rogawski R Ro Rog Roga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,() 3 9 0 0 0 0 1
drugs. Nat drugs. d dr dru drug BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .():- 5 5 0 0 0 0 1
Rogawski MA, rogawski R Ro Rog Roga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,(): 4 9 0 0 0 0 1
mechanisms and mechanisms m me mec mech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 - 1 9 0 0 0 0 1
ing developmental ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 11 6 .(): 4 8 0 0 0 0 1
223-286 223-286 223-286 2 22 223 223- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 - 1 1 0 0 0 0 1
Smart BE smart S Sm Sma Smar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 11 6 ()(). 5 9 0 0 0 0 1
J Fluorine j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 6 ():- 4 4 0 0 0 0 1
Song B, song S So Son Song BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 11 6 ,,,,,() 7 9 0 0 0 0 1
bioactivity of bioactivity b bi bio bioa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 - 1 9 0 0 0 0 1
moiety. J moiety. m mo moi moie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 .():- 5 5 0 0 0 0 1
Willow M, willow W Wi Wil Will BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 11 6 ,()[]- 6 9 0 0 0 0 1
chotoxinin A chotoxinin c ch cho chot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 -- 2 8 0 0 0 0 1
anticonvulsant drugs anticonvulsant a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 . 1 8 0 0 0 0 1
Mol Pharmacol mol M Mo Mol Mol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ():- 4 4 0 0 0 0 1
Willow M, willow W Wi Wil Will BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 11 6 ,,()- 5 9 0 0 0 0 1
sensitive sodium sensitive s se sen sens BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 - 1 8 0 0 0 0 1
somes by somes s so som some BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 no 0 8 0 0 0 0 1
carbamazepine. Mol carbamazepine. c ca car carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 .():- 5 6 0 0 0 0 1
Willow M, willow W Wi Wil Will BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 11 6 ,,() 4 9 0 0 0 0 1
the inhibitory the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 no 0 9 0 0 0 0 1
on voltage-sensitive on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 -. 2 8 0 0 0 0 1
Mol Pharmacol mol M Mo Mol Mol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ():- 4 4 0 0 0 0 1
Wong MG, wong W Wo Won Wong BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 6 ,,() 4 9 0 0 0 0 1
of clinically of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 . 1 7 0 0 0 0 1
29(4):562-572 29(4):562-572 29(4):562-572 2 29 29( 29(4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 ():- 4 2 0 0 0 0 1
World Health world W Wo Wor Worl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 6 ():.: 5 10 0 0 0 0 1
www.who.int/mediacentre/factsheets/fs999/en www.who.int/mediacentre/factsheets/fs999/en www.who.int/mediacentre/factsheets/fs999/en w ww www www. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 ..//// 6 6 0 0 0 0 1
Med Chem med M Me Med Med BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 ():- 4 10 0 1 0 0 0
3061 3061 3061 3 30 306 3061 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 11 no 0 1 0 1 0 0 0
123 123 123 1 12 123 123 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 11 no 0 10 0 0 0 0 0

